DecisionPoint Systems (DPSIP) 10-Q15 May 152015 Q1 Quarterly reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
Document and Entity Information	Mar. 31, 2015	8-May-15
Document and Entity Information [Abstract]
Entity Registrant Name	DecisionPoint Systems, Inc.
Entity Central Index Key	1505611
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Document Type	10-Q
Document Period End Date	31-Mar-15
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		12,729,563

Unaudited_Condensed_Consolidat

Unaudited Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Current assets
Cash	$818	$1,616
Accounts receivable, net	5,782	11,497
Inventory, net	1,573	2,035
Deferred costs	3,020	3,177
Deferred tax assets	13	21
Prepaid expenses and other current assets	209	81
Total current assets	11,415	18,427
Property and equipment, net	168	145
Other assets, net	116	124
Deferred costs, net of current portion	1,235	1,314
Goodwill	8,023	8,202
Intangible assets, net	1,660	2,045
Total assets	22,617	30,257
Current liabilities
Accounts payable	7,352	10,000
Accrued expenses and other current liabilities	2,150	2,755
Lines of credit	3,453	5,811
Current portion of debt	614	813
Due to related parties	107	73
Unearned revenue	6,266	6,918
Total current liabilities	19,942	26,370
Long term liabilities
Unearned revenue, net of current portion	1,860	2,015
Debt, net of current portion and discount	1,373	1,580
Deferred tax liabilities	431	460
Warrant liability	597	519
Other long term liabilities	206	226
Total liabilities	24,409	31,170
Commitments and contingencies
STOCKHOLDERS' DEFICIT
Cumulative Convertible Preferred stock, $0.001 par value, 10,000,000 shares authorized, 1,547,845 shares issued and outstanding, including cumulative and imputed preferred dividends of $2,322 and $2,295, and with a liquidation preference of $13,775 and $13,640 at March 31, 2015 and December 31, 2014, respectively	12,849	12,822
Common stock, $0.001 par value, 100,000,000 shares authorized, 12,883,446 issued and 12,729,563 outstanding as of March 31, 2015, and as of December 31, 2014	13	13
Additional paid-in capital	17,257	17,252
Treasury stock, 153,883 shares of common stock	-205	-205
Accumulated deficit	-31,259	-30,292
Unearned ESOP shares	-446	-484
Accumulated other comprehensive income	-1	-19
Total stockholders' deficit	-1,792	-913
Total liabilities and stockholders' deficit	$22,617	$30,257

Unaudited_Condensed_Consolidat1

Unaudited Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Statement Of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shared authorized	10,000,000	10,000,000
Preferred stock, shares issued	1,547,845	1,547,845
Preferred stock, shares outstanding	1,547,845	1,547,845
Preferred stock, dividends (in dollars)	$2,322	$2,295
Preferred Stock, Liquidation preference (in dollars)	$13,775	$13,640
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shared authorized	100,000,000	100,000,000
Common Stock, shares issued	12,883,446	12,883,446
Common stock, shares outstanding	12,729,563	12,729,563
Treasury stock, shares	153,883	153,883

Unaudited_Condensed_Consolidat2

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Income Statement [Abstract]
Net sales	$11,749	$16,709
Cost of sales	9,167	13,135
Gross profit	2,582	3,574
Selling, general and administrative expense	2,857	3,717
Operating loss	-275	-143
Other (income) expense:
Interest expense	184	207
Fair market value adjustment of warrant liability	78	-251
Other (income) expense, net	64	-8
Total other (income) expense	326	-52
Loss before income taxes	-601	-91
(Benefit) provision for income taxes	-21	22
Net loss	-580	-113
Cumulative and imputed dividends on Series A and B preferred stock	-27	-27
Cash and imputed dividends on Series D and E preferred stock		-302
Accrued paid-in-kind dividends on Series D and Series E preferred stock	-360
Net loss attributable to common shareholders	-967	-442
Net loss per common share:
Basic and diluted	($0.08)	($0.04)
Weighted average common shares outstanding:
Basic and diluted	12,425,182	12,314,498
Other comprehensive loss, net of tax
Net loss	-580	-113
Foreign currency translation adjustment	18	-24
Comprehensive loss	($562)	($138)

Unaudited_Condensed_Consolidat3

Unaudited Condensed Consolidated Statements of Cash Flows (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities:
Net loss	($580)	($113)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	282	451
Amortization of deferred financing costs and note discount	35	65
Employee and Director stock-based compensation	33	10
Change in fair value of warrants	78	-251
ESOP compensation expense	10	14
Allowance for doubtful accounts	16	-6
Deferred taxes, net	7
Changes in operating assets and liabilities:
Accounts receivable	5,665	925
Inventory, net	462	46
Deferred costs	233	-51
Prepaid expenses and other current assets	-54
Other assets, net		-25
Accounts payable	-2,640	-486
Accrued expenses and other current liabilities	-715	-116
Due to related parties	33	89
Unearned revenue	-757	8
Net cash provided by operating activities	2,108	560
Cash flows from investing activities
Purchases of property and equipment	-33	-19
Net cash used in investing activities	-33	-19
Cash flows from financing activities
Repayments from lines of credit, net	-2,353	-182
Repayment of debt	-249	-271
Dividends paid	-252
Paid financing costs	-100	-100
Net cash used in financing activities	-2,954	-553
Effect on cash of foreign currency translation	81	-17
Net decrease in cash	-798	-29
Cash at beginning of period	1,616	641
Cash at end of period	818	612
Supplemental disclosures of cash flow information:
Interest paid	249	269
Income taxes paid	54
Supplemental disclosure of non-cash financing activities:
Accrued and imputed dividends on preferred stock	27	329
Accrued PIK dividends on Series D and Series E preferred stock	$360

Description_of_Business

Description of Business	3 Months Ended
Description of Business	Mar. 31, 2015
Description of Business [Abstract]
DESCRIPTION OF BUSINESS	NOTE 1 - DESCRIPTION OF BUSINESS



	Description of Business



	DecisionPoint Systems, Inc., (“DecisionPoint”, “Company”) through its subsidiaries is an enterprise mobility systems integrator that sells and installs mobile computing and wireless systems that are used both within a company’s facilities in conjunction with wireless networks and in the field using carrier-based wireless networks. These systems generally include mobile computers, mobile application software, and related data capture equipment including bar code scanners and radio frequency identification (“RFID”) readers. The Company also provides professional services, proprietary and third party software and software customization as an integral part of its customized solutions for its customers. The suite of software products utilizes the latest technologies to empower the mobile worker in many areas including merchandising, sales and delivery; field service; logistics and transportation; and warehouse management.

Basis_of_Presentation_Liquidit

Basis of Presentation, Liquidity and Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2015

Basis of Presentation, Liquidity and Summary of Significant Accounting Policies [Abstract]

BASIS OF PRESENTATION, LIQUIDITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - BASIS OF PRESENTATION, LIQUIDITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all of the adjustments (consisting of normal recurring accruals and adjustments) necessary to present fairly the consolidated financial position, results of operations and cash flows of the Company at the dates and for the periods indicated. The interim results for the period ended March 31, 2015, are not necessarily indicative of results for the full 2015 fiscal year or any other future interim periods.

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, DecisionPoint Systems International and Apex Systems Integrators, Inc. “Apex”). DecisionPoint Systems International has two wholly-owned subsidiaries, DecisionPoint Systems Group, Inc. (“DPS Group”) and CMAC, Inc. (“CMAC”). The Company currently operates in one business segment.

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the recorded amounts reported therein. Certain accounting policies involve judgments and uncertainties to such an extent that there is reasonable likelihood that materially different amounts could have been reported under different conditions, or if different assumptions had been used. The Company evaluates its estimates and assumptions on a regular basis. The Company uses historical experience and various other assumptions that are believed to be reasonable under the circumstances to form the basis for making judgments about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates and assumptions used in preparation of the unaudited condensed consolidated financial statements.

These accompanying unaudited condensed consolidated financial statements have been prepared by management and should be read in conjunction with the audited consolidated financial statements of DecisionPoint Systems, Inc. and notes thereto for the year ended December 31, 2014, included in the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 18, 2015.

Going Concern

The accompanying unaudited condensed consolidated financial statements were prepared on a going concern basis in accordance with U.S. GAAP. The going concern basis of presentation assumes that the Company will continue in operation for the next twelve months and will able to realize its assets and discharge its liabilities and commitments in the normal course of business and does not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the Company’s inability to continue as a going concern. The Company’s history of losses, working capital deficit, capital deficit, minimal liquidity and other factors raise substantial doubt about the Company’s ability to continue as a going concern. In order for the Company to continue operations beyond the next twelve months and be able to discharge its liabilities and commitments in the normal course of business, the Company must establish sustained positive operating results through increased sales, avoid further unforeseen expenses, improve liquidity and working capital, and potentially raise additional equity or debt capital. There can be no assurance that the Company will be able to achieve sustainable positive operating results or obtain additional funds when needed or that such funds, if available, will be obtainable on terms satisfactory to management.

If the Company does not achieve sustained positive operating results and does not raise sufficient additional capital, material adverse events may occur including, but not limited to, (1) a reduction in the nature and scope of the Company’s operations, (2) the Company’s inability to fully implement its current business plan and (3) defaults under the Company’s various loan agreements (for a description of past defaults, see the discussion below). If such events were to occur, they would have material adverse effects on the Company. There can be no assurance that the Company will successfully improve its liquidity position. The consolidated financial statements do not reflect any adjustments that might be required resulting from the adverse outcome relating to this uncertainty.

Summary of Significant Accounting Policies

There have been no material changes to the Company's significant accounting policies during the three months ended March 31, 2015. See Note 2 of the Company's consolidated financial statements included in the Company's 2014 Annual Report on Form 10-K filed with the SEC on March 18, 2015, for a comprehensive description of the Company's significant accounting policies.

Revenue Recognition - Revenues are generated through product sales, warranty and maintenance agreements, software customization, and professional services. Product sales are recognized when the following criteria are met (1) there is persuasive evidence that an arrangement exists; (2) delivery has occurred and title has passed to the customer which generally happens at the point of shipment provided that no significant obligations remain; (3) the price is fixed and determinable; and (4) collectability is reasonably assured. The Company generates revenues from the sale of extended warranties on wireless and mobile hardware and systems. Revenue related to extended warranty and service contracts is recorded as unearned revenue and is recognized over the life of the contract as the Company maintains financial risk throughout the term of these contracts and may be liable to refund a customer for amounts paid in certain circumstances. Our policy is to classify shipping and handling costs billed to customers and the related expenses as cost of sales.

The Company also generates revenue from professional services and customer specified software customization on either a fee-for-service or fixed fee basis. Revenue from software customization and professional services that is contracted as fee-for-service is recognized in the period in which the services are performed or delivered. Adjustments to contract price and estimated labor costs are made periodically, and losses expected to be incurred on contracts in progress are charged to operations in the period such losses are determined. The Company records sales net of sales tax.

The Company enters into revenue arrangements that contain multiple deliverables. Judgment is required to properly identify the accounting units of the multiple deliverable transactions and to determine the manner in which revenue should be allocated among the accounting units. Moreover, judgment is used in interpreting the commercial terms and determining when all criteria of revenue recognition have been met for each deliverable in order for revenue recognition to occur in the appropriate accounting period. In an arrangement with multiple deliverables, the delivered item or items shall be considered a separate unit of accounting if both of the following criteria are met: (i) the delivered item or items have value to the customer on a standalone basis; and (ii) if the arrangement includes a general right of return relative to the delivered item, delivery or performance of the undelivered item or items is considered probable and substantially in the control of the vendor. A delivered item or items that do not qualify as a separate unit of accounting within the arrangement shall be combined with the other applicable undelivered item(s) within the arrangement and the allocation of arrangement consideration and the recognition of revenue then shall be determined for those combined deliverables as a single unit of accounting. While changes in the allocation of the arrangement consideration between the units of accounting will not affect the amount of total revenue recognized for a particular sales arrangement, any material changes in these allocations could affect the timing of revenue recognition, which could affect the Company’s results of operations. When the Company enters into an arrangement that includes multiple elements, we allocate revenue based on their relative selling prices. We use a hierarchy to determine the selling price to be used for allocating revenue to deliverables: (i) vendor specific objective evidence of fair value (“VSOE”), (ii) third party evidence of selling prices (“TPE”) and (iii) best estimate of selling price (“ESP”) as a proxy for VSOE. When both VSOE and TPE are unavailable, we use ESP. We determine ESP by considering all relevant factors in establishing the price.

Revenue from software licenses may contain arrangements with multiple deliverables, including post-contract customer support, that are subject to software revenue recognition guidance. The revenue for these arrangements is allocated to the software and non-software deliverable based on the relative selling prices of all components in the arrangement using the criteria above. Post-contract support is recognized ratably over the support period. When a contract contains multiple elements wherein the only undelivered element is post-contract customer support and VSOE of the fair value of post-contract customer support does not exist, revenue from the entire arrangement is recognized ratably over the support period. Software royalty revenue is recognized in arrears on a quarterly basis, based upon reports received from licensees during the period, unless collectability is not reasonably assured, in which case revenue is recognized when payment is received from the licensee.

Concentration of Risk - Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash, accounts receivable, and accounts payable. Beginning January 1, 2013, all of our cash balances were insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 per depositor at each financial institution. This coverage is available at all FDIC member institutions. The Company uses Silicon Valley Bank, which is an FDIC insured institution. Based on these facts, collectability of bank balances appears to be adequate.

Historically, a relatively small number of customers have accounted for a significant portion of the Company’s revenue. The Company had one customer who represented 10% and 11% of the Company’s revenue for the three months ended March 31, 2015 and 2014, respectively. The Company had three customers, two of which were not the same, who represented 24% and 25% of its revenue for the three months ended March 31, 2015 and 2014, respectively. The Company’s accounts receivable was concentrated with one customer, which was the same, representing 14% and 16% of gross accounts receivable at March 31, 2015 and 2014, respectively. Customer mix can shift significantly from year to year, but a concentration of the business with a few large customers is typical in any given year. A decline in revenues could occur if a customer that has been a significant source of revenue in one financial reporting period is a less significant source of revenue in the following period. The loss of a significant customer could have a material adverse impact on the Company.

The Company has four primary vendors for the three months ended March 31, 2015, one of which was not the same when compared to the similar period in 2014. For the three months ended March 31, 2015, the Company had purchases from these four vendors that collectively represented 58% of total purchases and 71% of the total outstanding accounts payable at March 31, 2015. For the three months ended March 31, 2014, the Company had purchases from these four vendors that collectively represented 60% of total purchases and 65% of the total outstanding accounts payable at March 31, 2014. The same single vendor represented 24% and 29% of the total purchases for the three months ended March 31, 2015 and 2014, respectively. Loss of this certain vendor could have a material adverse effect on our operations.

The Company’s contracts with these customers and other customers do not include any specific purchase requirements or other requirements outside of the normal course of business. The majority of customer contracts are on an annual basis for service support while on a purchase order basis for hardware purchases. Typical hardware sales are submitted on an estimated order basis with subsequent follow on orders for specific quantities. These sales are ultimately subject to the time that the units are installed at each of the customer locations as per their requirements. Service contracts are purchased on an annual basis generally and are the performance responsibility of the actual service provider as opposed to the Company. Termination provisions are generally standard clauses based upon non-performance, but a customer can cancel with a certain reasonable notice period anywhere from 30 to 90 days. General industry standards for contracts provide ordinary terms and conditions, while actual work and performance aspects are usually dictated by a Statement of Work which outlines what is being ordered, product specifications, delivery, installation and pricing.

Translation of Foreign Currencies - The Company's functional currency is the U.S. dollar. The financial statements of the Company's foreign subsidiary is measured using the local currency, in this case the Canadian dollar (CDN$), as its functional currency and is translated to U.S. dollars for reporting purposes. Assets and liabilities of the subsidiary are translated at exchange rates as of the balance sheet dates. Revenues and expenses of the subsidiary are translated at the rates of exchange in effect during the year.

Fair Value Measurement - Fair value is the price that would be received from selling an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants as of the measurement date. Applicable accounting guidance provides a hierarchy for inputs used in measuring fair value that prioritize the use of observable inputs over the use of unobservable inputs, when such observable inputs are available. The three levels of inputs that may be used to measure fair value are as follows:

Level 1 - Quoted prices in active markets for identical assets or liabilities.

Level 2 - Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions (less active markets), or model-driven valuations in which all significant inputs are observable or can be derived principally from, or corroborated with, observable market data.

Level 3 - Fair value is derived from valuation techniques in which one or more significant inputs are unobservable, including assumptions and judgments made by the Company.

Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. The Company reviews the fair value hierarchy classification on a quarterly basis. Changes in the observable inputs may result in a reclassification of assets and liabilities within the three levels of the hierarchy outlined above.

Liabilities Measured and Recorded at Fair Value on a Recurring Basis

The Company measures certain liabilities at fair value on a recurring basis such as our contingent consideration related to business combinations and recognizes transfers within the fair value hierarchy at the end of the fiscal quarter in which the change in circumstances that caused the transfer occurred. There have been no transfers between Level 1, 2 or 3 assets or liabilities during the fiscal three months ended March 31, 2015.

The Company is obligated to pay bonus consideration to the former CEO of Apex. Such bonus is considered additional contingent purchase consideration as the Company is obligated to pay the bonus regardless of whether or not the CEO’s employment is retained. The fair value of the bonus was calculated to be approximately CDN$160,000 (US$153,000 at the Closing Date). The Company reassessed the fair value of the contingent consideration liability at December 31, 2014 and determined the amount to be $0. The Company continues to recognize no bonus consideration obligation in 2015.

The Company has classified certain warrants related to the August 2013 issuance and sale of common stock in a private offering as a Level 3 Liability. Assumptions used in the calculation require significant judgment. The Company reassesses the fair value of the warrant liabilities on a quarterly basis using a Monte Carlo option pricing model. Based on that assessment, the Company recognized a $78,000 increase and a $251,000 decrease to the fair value of the warrants during the three months ended March 31, 2015 and 2014, respectively.

The following table summarizes the financial liabilities measured at fair value on a recurring basis as of March 31, 2015 and December 31, 2014 (in thousands):

Significant other

Quoted prices in

Significant other

unobservable

active markets

observable inputs

inputs

Total

Level 1

Level 2

Level 3

Liabilities

Fair value of warrants issued in connection

with share purchase agreement

597

Balance at March 31, 2015

597

Significant other

Quoted prices in

Significant other

unobservable

active markets

observable inputs

inputs

Total

Level 1

Level 2

Level 3

Liabilities

Fair value of warrants issued in connection

with share purchase agreement

519

Balance at December 31, 2014

519

The following table summarizes changes to the fair value of the contingent consideration and derivative warrants, which are Level 3 liabilities (in thousands):

Level 3

Derivative

warrants

Balance at December 31, 2014

519

Adjustments to fair value of warrants (reflected in other income)

Balance at March 31, 2015

597

Assets Measured and Recorded at Fair Value on a Nonrecurring Basis

The Company's non-financial assets and liabilities, such as goodwill, intangible assets, and other long lived assets resulting from business combinations are measured at fair value using income and market comparable valuation methodologies at the date of acquisition and subsequently re-measured if there are indicators of impairment. There were no indicators of impairment identified during the three months ended March 31, 2015.

Income Taxes - We account for income taxes in accordance with the Financial Accounting Standards Board (“FASB”) guidance, which requires deferred tax assets and liabilities, be recognized using enacted tax rates to measure the effect of temporary differences between book and tax bases on recorded assets and liabilities. FASB guidance also requires that deferred tax assets be reduced by a valuation allowance, if it is more likely than not some portion or all of the deferred tax assets will not be recognized.

For the three months ended March 31, 2015, the Company recorded a tax benefit of $21,000 on pre-tax loss of $0.6 million, compared to an income tax expense of $22,000 on pre-tax loss of $91,000 for the three months ended March 31, 2014.

Recently Issued Accounting Pronouncements – In April 2015, the FASB issued Accounting Standards Update (“ASU”) ASU 2015-03, “Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs.” The update requires debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability instead of being presented as an asset. This guidance is effective for public companies for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those years. For all other entities, this guidance is effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within fiscal years beginning after December 15, 2016. Early adoption is permitted for financial statements that have not been previously issued. The new guidance is to be applied on a retrospective basis, wherein the balance sheet of each individual period presented is adjusted to reflect the period-specific effects of applying the new guidance and represents a change in accounting principle. Management is currently evaluating the impact of the adoption of this accounting standard update on its financial statements.

In April 2015, the FASB issued ASU 2015-05, “Intangibles–Goodwill and Other–Internal Use Software (Subtopic 350-40): Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement.” This update provides guidance to customers about whether a cloud computing arrangement includes a software license. If a cloud computing arrangement includes a software license, then the customer should account for the software license element of the arrangement consistent with the acquisition of other software licenses. This guidance is effective for public companies for fiscal years and interim periods beginning after December 15, 2015. For all other entities, this guidance is effective for annual periods beginning after December 15, 2015, and interim periods within fiscal years beginning after December 15, 2016. Early adoption is permitted for all entities. The new guidance is to be applied either prospectively to new cloud computing arrangements or retrospectively. Management is currently evaluating the impact of the adoption of this accounting standard update on its financial statements.

Loss_Per_Common_Share

Loss Per Common Share	3 Months Ended
Loss Per Common Share	Mar. 31, 2015
Loss Per Common Share [Abstract]
LOSS PER COMMON SHARE	NOTE 3 – LOSS PER COMMON SHARE



	Basic loss per share is computed by dividing the loss available to common shareholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similarly to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The weighted-average basic and diluted shares for each of the three months ended March 31, 2015 and 2014, exclude approximately 0.3 million and 0.4 million, respectively, of ESOP shares that have not been committed to be released.



	For periods presented in which there is a net loss, potentially dilutive securities are excluded from the computation of fully diluted net loss per share as their effect is anti-dilutive. All potentially dilutive securities are anti-dilutive due to the net loss incurred by the Company in the periods presented.



	Potential dilutive securities consist of (in thousands):

		Three Months Ended March 31,
		2015		2014

	Convertible preferred stock - Series A		270		270
	Convertible preferred stock - Series B		131		131
	Convertible preferred stock - Series D		10,287		9,918
	Convertible preferred stock - Series E		8,331		8,180
	Warrants to purchase common stock		3,279		3,555
	Options to purchase common stock		1,462		592

	Total potentially dilutive securities		23,760		22,646

Warrant_Liability

Warrant Liability	3 Months Ended
Warrant Liability	Mar. 31, 2015
Warrant Liability [Abstract]
WARRANT LIABILITY	NOTE 4 – WARRANT LIABILITY



	The Company has determined that certain warrants the Company has issued contain provisions that protect the holders from future issuances of the Company’s Common Stock at prices below such warrants’ then in effect respective exercise prices (see Note 9). These provisions could result in modification of the warrants then in effect exercise price. The Company evaluated the guidance ASC 480-10 Distinguishing Liabilities from Equity and ASC 815-40 Contracts in an Entity’s Own Equity. Pursuant to this guidance, the Company’s management concluded that these instruments do not meet the criteria for classification as equity treatment and must be recorded as a liability as a result of the terms in the warrants that provide for price protection in the event of a future issuance. The Company recognized these warrants as liabilities at their fair value and re-measures them at fair value on each reporting date. ASC 820 Fair Value Measurement provides requirements for disclosure of liabilities that are measured at fair value on a recurring basis in periods subsequent to the initial recognition (see Note 2).



	The Company uses Level 3 inputs for its valuation methodology for the warrant derivative liabilities. The estimated fair values were determined using a Monte Carlo option pricing model based on various assumptions. The Company’s derivative liabilities are adjusted to reflect estimated fair value at each period end, with any decrease or increase in the estimated fair value being recorded in other income or expense accordingly, as adjustments to the fair value of derivative liabilities. Various factors are considered in the pricing models the Company uses to value the warrants, including the Company’s current common stock price, the remaining life of the warrants, the volatility of the Company’s common stock price, and the risk-free interest rate. In addition, as of the valuation dates, management assessed the probabilities of future financing assumptions in the Monte Carlo valuation models. Future changes in these factors will have a significant impact on the computed fair value of the warrant liability. Accordingly, the Company expects future changes in the fair value of the warrants to continue to vary from quarter to quarter.

	The Company revalues the warrants as of the end of each reporting period. The estimated fair value of the outstanding warrant liabilities was approximately $597,000 and $519,000, as of March 31, 2015 and December 31, 2014, respectively. The increase in fair value of the warrant liabilities for the three months ended March 31, 2015 was $78,000 while the decrease in the fair value of the warrant liabilities for the three months ended March 31, 2014 was $251,000. The adjustments to the fair value of the warrant liabilities are included in other income in the Company’s unaudited condensed consolidated statements of operations.

	The warrant liabilities were valued at the closing dates of the Purchase Agreement and the end of each reporting period using a Monte Carlo valuation model with the following assumptions:

			Placement Agent Warrants						Investor Warrants
	Warrants		March			December			March			December
	Warrants		31, 2015			31, 2014			31, 2015			31, 2014

	Closing price per share of common stock	$	0.42		$	0.38		$	0.42		$	0.38
	Exercise price per share (range)		0.5			0.5			0.5			0.5
	Expected volatility		147	%		138.3	%		147	%		138.6	%
	Risk-free interest rate		1	%		1.3	%		1	%		1.3	%
	Dividend yield		-			-			-			-
	Remaining expected term of underlying		3.4			3.6			3.4			3.6
	securities (years)		3.4			3.6			3.4			3.6

Business_Combinations

Business Combinations	3 Months Ended
Business Combinations	Mar. 31, 2015
Business Combinations [Abstract]
BUSINESS COMBINATIONS	NOTE 5 – BUSINESS COMBINATIONS



	In pursuing our business strategies, we acquire and make investments in certain businesses that meet strategic and financial criteria.



	Illume Mobile



	On July 31, 2012 (“Illume Closing Date”), the Company consummated an asset purchase agreement (“Asset Purchase Agreement”) with MacroSolve, Inc. Pursuant to the Asset Purchase Agreement, the Company purchased the business (including substantially all the related assets) of the seller’s Illume Mobile division (“Illume Mobile”), based in Tulsa, Oklahoma. Founded in 1996, Illume Mobile is a mobile business solutions provider that serves mobile products and platforms. Illume Mobile’s initial core business is the development and integration of business applications for mobile environments. The Company accounted for the transaction using the purchase method of accounting and the operating results for Illume Mobile have been consolidated into the Company’s results of operations beginning on August 1, 2012.



	In consideration for the business of Illume Mobile, the Company paid $1,000,000, of which $250,000 was paid in cash and $750,000 was paid in the form of 617,284 shares of the Company’s common stock. The Company valued the shares issued in conjunction with the acquisition at $697,531.



	Apex



	On June 4, 2012 (the “Apex Closing Date”), pursuant to a Stock Purchase Agreement (the “Apex Purchase Agreement”), the Company acquired all of the issued and outstanding shares of Apex, a corporation organized under the laws of the Province of Ontario, Canada. Apex is a provider of wireless mobile work force software solutions. Its suite of products utilizes the latest technologies to empower the mobile worker in many areas including merchandising, sales and delivery; field service; logistics and transportation; and, warehouse management. Its clients are North American companies that are household names whose products and services are used daily to feed, transport, entertain and care for people throughout the world. The Company accounted for the transaction using the purchase method of accounting and the operating results for Apex have been consolidated into the Company’s results of operations beginning on June 5, 2012.



	In consideration for the shares of Apex, the Company paid CDN$5,000,000 (US$4,801,000 at the Closing Date) (the “Apex Closing Amount”) in cash. The Company may have been required to pay up to an undiscounted amount of CDN$3,500,000 (US$3,360,700 at the Closing Date) in consideration for Apex achieving certain levels of adjusted earnings before interest, depreciation, taxes and amortization (the “EBITDA”), as defined by the Apex Purchase Agreement, in the period ended July 2013. The initial fair value of the earn-out (the “Apex Earn-Out Payment”) was calculated to be approximately CDN$1,076,000 (US$1,033,000 at the Closing Date). At September 30, 2013, the calculated Apex Earn-Out Payment due under the Apex Purchase Agreement was CDN$341,000 (US$331,000). The adjustment of CDN$735,000 (US$713,000) was recorded as a separate component of operating expenses in the unaudited condensed consolidated statement of operations and comprehensive loss as of September 30, 2013. On June 9, 2014, an independent accounting expert issued their final report and the fair value of the Apex Earn-Out Payment was calculated to be CDN$400,000 of which CDN$89,000 (US$84,000) (22.22%) was paid in cash and CDN$311,000 (US$291,000) (77.78%) payable in the form of a convertible promissory note. The convertible promissory note was executed in December 2014.

	As part of the Apex Purchase Agreement, the Company is obligated to pay bonus consideration to the CEO of Apex. Such bonus is considered additional contingent purchase consideration as the Company is obligated to pay the bonus regardless of whether or not the CEO’s employment is retained. The initial fair value of the bonus was calculated to be approximately CDN$160,000 (US$153,000 at the Closing Date). The Company reassessed the fair value of the contingent consideration liability at March 31, 2015 and December 31, 2014 and determined the amount to be $0. The Company continues to recognize no bonus consideration obligation in 2015.

Goodwill_and_Intangible_Assets

Goodwill and Intangible Assets	3 Months Ended
Goodwill and Intangible Assets	Mar. 31, 2015
Goodwill and Intangible Assets [Abstract]
GOODWILL AND INTANGIBLE ASSETS	NOTE 6 – GOODWILL AND INTANGIBLE ASSETS



	The following summarizes the transactions effecting goodwill through March 31, 2015 (in thousands):



	Balance at December 31, 2014	$	8,202

	Effect of currency translation on Apex		(179	)
	Balance at March 31, 2015	$	8,023



	As of March 31, 2015 and December 31, 2014, the Company’s intangible assets and accumulated amortization consist of the following (in thousands):



		31-Mar-15								31-Dec-14
						Accumulated							Accumulated
			Gross			Amortization			Net		Gross		Amortization			Net

	Customer relationships	$	3,033		$	(2,114	)	$	919	$	3,144	$	(2,099	)	$	1,045
	Contractor and resume databases		675			(574	)		101		675		(540	)		135
	Tradename		798			(560	)		238		829		(546	)		283
	Internal use software		2,429			(2,027	)		402		2,607		(2,025	)		582
	Covenant not to compete		102			(102	)		0		103		(103	)		-

		$	7,037		$	(5,377	)	$	1,660	$	7,358	$	(5,313	)	$	2,045



	The effect of foreign currency translation on the goodwill and intangible assets for the three months ended March 31, 2015 is approximately ($179,000) and ($113,000).

Lines_of_Credit

Lines of Credit	3 Months Ended
Lines of Credit	Mar. 31, 2015
Lines of Credit [Abstract]
LINES OF CREDIT	NOTE 7 – LINES OF CREDIT



	SVB Line of Credit - The Company has a $10.0 million revolving line of credit with Silicon Valley Bank (“SVB”) which provides for borrowings based upon eligible accounts receivable, as defined in the Loan Agreement (“SVB Loan Agreement”). Under the SVB Loan Agreement as amended February 27, 2013, SVB has also provided the Company with term loans as discussed at Note 8. On February 27, 2015, the Company entered into an agreement to further amend the original SVB Loan Agreement dated December 15, 2006 to extend the maturity date of the revolving credit line provided thereunder to February 28, 2017. The February 27, 2015 amendment provides for interest at prime plus 3.25% in 2015, and provides for further interest rate reductions upon achievement of certain financial thresholds. The SVB Loan Agreement is secured by substantially all the assets of the Company. As of March 31, 2015 and December 31, 2014, the outstanding balance on the line of credit was approximately $3.5 and $5.8 million, respectively, and the interest rate was 6.5%.



	Availability under the line of credit was approximately $0.7 million as of March 31, 2015. The line of credit allows the Company to cause the issuance of letters of credit on account of the Company to a maximum of the borrowing base as defined in the Loan Agreement. No letters of credit were outstanding as of March 31, 2015 or December 31, 2014.



	The February 27, 2015 amendment has certain financial covenant and other non-financial covenants. The minimum Tangible Net Worth requirement of an $8.6 million deficit, which is to be further reduced by one half of any funds raised through sales of common stock (as only 50% of additional capital raises are given credit in the Tangible Net Worth calculation) on or after February 1, 2015. The Company believes that at the time of this filing it is compliant with the terms and provisions of its amended SVB Loan Agreement. Should the Company incur losses in a manner consistent with its recent historical financial performance, the Company will violate Tangible Net Worth covenant without additional net capital raises in amounts that are approximately twice the amount of the losses incurred.



	RBC Line of Credit - The Company is party to a credit agreement, dated June 4, 2012 (the “RBC Credit Agreement”) with Royal Bank of Canada (“RBC”). Under the RBC Credit Agreement, the revolving demand facility allows for borrowings up to CDN$200,000 based upon eligible accounts receivable. Interest is based on the Royal Bank Prime (“RBP”) plus 1.5% and is payable on demand. As of March 31, 2015 and December 31, 2014, the outstanding balance on the line of credit was $0 and $58,000, respectively, and the interest rate is 4.35%. The RBC Credit Agreement is secured by the assets of Apex. The revolving demand facility has certain financial covenants and other non-financial covenants. The covenants were reset by RBC on August 16, 2013. The Company was in compliance with the reset covenants at March 31, 2015 and December 31, 2014. See further discussion regarding this condition at Note 8.



	For the three months ended March 31, 2015 and 2014, the Company’s interest expense for the lines of credit, including amortization of deferred financing costs, was approximately $103,000 and $97,000, respectively.



	RBC and SVB are party to a subordination agreement, pursuant to which RBC agreed to subordinate any security interest in assets of the Company granted in connection with the RBC Credit Agreement to SVB’s security interest in assets of the Company.



	Under the RBC Credit Agreement, the lender provided Apex with a term loan as discussed at Note 8.

Term_Debt

Term Debt	3 Months Ended
Term Debt	Mar. 31, 2015
Term Debt [Abstract]
TERM DEBT	NOTE 8 – TERM DEBT



	Term debt as of March 31, 2015, consists of the following (in thousands):




		Balance			Additions		Payments			Amortization of Note Discount		Effect of				Balance
		31-Dec-14										Currency				March 31,
												Translation				2015
	RBC term loan	$	358		$	-	$	(165	)	$	-	$	(28	)		$	165

	BDC term loan		1,462			-		-		-		(118	)			1,344

	SVB term loan		389			-		(83	)		-		-				306

	Note payable seller		200			-		-			-		(16	)			184

	Total note discounts		(16	)		-		-			4		-				(12	)

	Total debt	$	2,393		$	-	$	(279	)	$	4	$	(162	)		$	1,987

	less current portion																(614	)

	Debt, net of current portion														$	1,373





	The Company’s debt is recorded at par value adjusted for any unamortized discounts. Discounts and costs directly related to the issuance of debt are capitalized and amortized over the life of the debt using the effective interest rate method and is recorded in interest expense in the accompanying unaudited condensed consolidated statements of operations. Unamortized deferred financing costs of approximately $11,000 and $19,000 are included in other assets in the accompanying unaudited condensed consolidated balance sheets as of March 31, 2015 and December 31, 2014, respectively.



	RBC Term Loan -- On June 4, 2012, Apex entered into the RBC Credit Agreement with RBC described in Note 7, pursuant to which RBC made available certain credit facilities in the aggregate amount of up to CDN$2,750,000, including a term facility (“RBC Term Loan”) in the amount of CDN $2,500,000 (US$2,401,000 at the Closing Date). The RBC Term Loan accrues interest at RBP plus 4% (7% at March 31, 2015). Principal and interest is payable over a three year period at a fixed principal amount of CDN $70,000 a month beginning in July 2012 and continuing through June 2015. Apex paid approximately $120,000 in financing costs, which has been recorded as deferred financing costs or note discount in the accompanying unaudited condensed consolidated balance sheet as of March 31, 2015 and December 31, 2014, and is being amortized to interest expense over the term of the loan.



	In addition, the RBC Term Loan calls for mandatory repayments based on 20% of Apex’s free cash flow as defined in the RBC Credit Agreement, before discretionary bonuses based on the annual year end audited financial statements of Apex, beginning with the fiscal year ended December 31, 2012, and payable within 30 days of the delivery of the annual audited financial statements, and continuing every six months through December 31, 2014. This amount was $0 at December 31, 2014.



	The RBC Term Loan has certain financial covenants and other non-financial covenants. On August 16, 2013 the RBC Credit Agreement was amended and certain financial covenants were modified. Pursuant to the amended credit agreement and commencing with the fiscal year ended December 31, 2013, the Company is required to maintain a fixed coverage ratio, calculated on a consolidated basis of not less than 1.15:1 with a step-up to 1.25:1 as of March 31, 2014, tested on a rolling four quarter basis thereafter and a ratio of funded debt to EBITDA, calculated on an annual consolidated basis of not greater than 3.0:1, tested on a rolling four quarter basis thereafter. The Company was in compliance with all of our RBC financial covenants as of March 31, 2015 and December 31, 2014. We expect to continue to meet the requirements of our RBC financial covenants over the remainder of the loan period, final payment is scheduled for June 2015.



	BDC Term Loan -- On June 4, 2012, Apex also entered into the BDC Loan Agreement as part of the Apex Purchase Agreement described in Note 5, pursuant to which BDC made available to Apex a term credit facility (“BDC Term Loan”) in the aggregate amount of CDN $1,700,000 (USD $1,632,000 at the Closing Date). The BDC Term Loan accrues interest at the rate of 12.5% per annum, and matures on June 23, 2016, with an available one year extension for a fee of 2%, payable at the time of extension. The Company does not currently have the liquidity to repay this obligation when due. In addition to the interest payable, consecutive quarterly payments of CDN$20,000 as additional interest are due beginning on June 23, 2012, and subject to compliance with bank covenants, Apex will make a mandatory annual principal payment in the form of a cash flow sweep which will be equal to 50% of the Excess Available Funds (as defined by the BDC Loan Agreement) before discretionary bonuses based on the annual year end audited financial statements of Apex. The maximum annual cash flow sweep in any year will be CDN$425,000. As of March 31, 2015, the Company estimates that the cash sweep will be approximately $0. Such payments will be applied to reduce the outstanding principal payment due on the maturity date. In the event that Apex’s annual audited financial statements are not received within 120 days of its fiscal year end, the full CDN$425,000 becomes due and payable on the next payment date. Apex paid approximately $70,000 in financing costs which $35,000 has been recorded as deferred financing costs and $35,000 recorded as a note discount in the accompanying consolidated balance sheet and is being amortized to interest expense over the term of the loan using the effective interest rate method. As of March 31, 2015, there was approximately $10,000 in unamortized deferred financing costs and $10,000 in unamortized note discount.



	The terms of the BDC loan agreement also provide for a fee to BDC in the event of the occurrence of any of the following:



	(a) if 50% or more of any company comprising Apex or the Company (consolidated assets or shares) is sold or merged with an unrelated entity; or



	(b) if there is a change of control of Apex and/or the Company prior to the Maturity Date or any extended maturity date of the BDC Tern Loan,



In the event of (a) or (b) above, Apex will pay to BDC a bonus in an amount equal to 2% of the aggregate value of Apex and the Company determined as at the closing date of such transaction, which bonus shall become due and payable at the time of the closing of such transaction. Notwithstanding any prepayment of the BDC Term Loan, the bonus and Apex’s obligation to pay same to the BDC will remain in full force and effect until the maturity date or any amended or extended maturity date agreed by the BDC such that in the event of any sale, initial public offering or similar transaction, Apex’s obligation to pay the bonus amount to the BDC will survive such prepayment.



The BDC Loan Agreement contains certain financial and non-financial covenants. On August 22, 2013, the BDC Term Loan was amended and certain financial covenants were modified. Pursuant to the amended loan agreement, the Company is required to maintain, for the duration of the investment, a term debt to equity ratio not exceeding 1.1:1 (measured annually); and an adjusted current ratio of 0.40:1 (measured annually) and revised yearly 120 days after each year end. The Company was in compliance with all of our BDC financial covenants as of December 31, 2014.



In the event either or both of the RBC Loan Agreement or the BDC Loan Agreement were deemed to be in default, RBC or BDC, as applicable, could, among other things (subject to the rights of SVB as the Company’s senior lender), terminate the facilities, demand immediate repayment of any outstanding amounts, and foreclose on our assets. Any such action would require us to curtail or cease operations, as the Company does not currently have alternative sources of financing.



SVB Term Loan - On December 31, 2010, pursuant to an Assumption and Amendment to Loan and Security Agreement ("Amended SVB Loan Agreement"), the Company borrowed $3.0 million from Silicon Valley Bank (“SVB”). The SVB Term Loan was due in 36 equal monthly installments of principal plus interest beginning on February 1, 2011. The SVB Term Loan is secured by substantially all of the assets of the Company except for the assets of Apex. On May 20, 2011, pursuant to a Consent and Amendment to Loan and Security Agreement (“Amendment”), the maturity date was amended to April 30, 2012, with the remaining principal due on that date to be paid as a balloon payment. The principal amount outstanding under the Term Loan accrues interest at a fixed rate equal to 9% per annum. In addition, a final payment equal to 2% of the aggregate amount of the Term Loan is due on the earlier of the maturity date or the date the Term Loan is prepaid. This final payment of $60,000 has been recorded as a discount to the SVB Term Loan, which was amortized to interest expense through December 2013, using the effective interest method.



The Amended SVB Loan Agreement includes various customary covenants, limitations and events of default. Financial covenants, among others, include liquidity and fixed charge coverage ratios, minimum tangible net worth requirements and limitations on indebtedness. As of March 31, 2015, the Company was in compliance with the tangible Net Worth financial covenant and had available a $0.9 million cushion over the requirement. The Company currently believes that at the time of this filing it is compliant with the terms and provisions of its SVB lending agreement and expects to continue to meet the requirements of our SVB financial covenants over the short and long term. Should the Company incur losses in a manner consistent with its recent historical financial performance, the Company will violate this covenant without additional net capital raises in amounts that are approximately twice the amount of the losses incurred.



On February 27, 2013, the Company amended the Loan and Security Agreement which provided an additional term loan (the “SVB Term Loan”) of $1,000,000. The new term loan is due in 36 monthly installments of principal plus accrued interest beginning on April 1, 2013. The additional term loan accrues interest at 7.5% per annum. As of March 31, 2015 and December 31, 2014, the outstanding balance on the SVB Term Loan was approximately $306,000 and $389,000, respectively.



On February 27, 2015, the Company further amended the SVB Loan Agreement to extend the maturity date of the revolving credit line provided thereunder to February 28, 2017. The February 27, 2015 amendment provides for interest at prime plus 3.25% in 2015, and provides for further interest rate reductions upon achievement of certain financial thresholds. The February 27, 2015 amendment contains certain financial covenants (see Note 7).



For the three months ended March 31, 2015 and 2014, the Company’s interest expense on the term debt, including amortization of deferred financing costs, was approximately $77,000 and $109,000, respectively.





In the event either or both RBC Loan Agreement and/or the BDC Loan Agreement were deemed to be in default, then the Amended SVB Loan agreement would be in default, which could, among other things, terminate the facility and term loan, demand immediate repayment of any outstanding amounts, and foreclose on our assets. Any such action would require us to curtail or cease operations, as the Company does not currently have alternative sources of financing.



Seller Note - In December 2014, the Company executed a convertible note payable with the seller of Apex for the fair value of the Apex Earn-Out. The note is payable in eight quarterly payments (“Installment Dates”) of principal and interest beginning July 1, 2014. The convertible notes accrues interest of 9% per annum for the first year and 11% for year two. The note is convertible, only on each Installment Date, at the option of the note holder, into shares of our common stock at a conversion price that is equal to the greater of the Canadian Dollar equivalent of the market price of our common stock on the day prior to the conversion using a fixed rate of US$1.00 =DN$1.04, or the Canadian Dollar equivalent of US$1.00 =DN$1.04. Given the fixed exchange rates, the embedded conversion option was not required to be bifurcated. The shares issuable under the note will be restricted but will have certain piggy back registration rights as set forth in the Apex Purchase Agreement. The convertible note matures in June 2016. As of March 31, 2014 and December 31, 2014, the outstanding balance on the Seller Note was approximately $184,000 and $200,000, respectively. As of the date of this filing, the quarterly payment due March 30, 2015 has not been paid. The Company is currently in default of the Seller Note as of the date of this filing.

Stockholders_Deficit

Stockholders' Deficit

3 Months Ended

Mar. 31, 2015

Stockholders' Deficit [Abstract]

STOCKHOLDERS' DEFICIT

NOTE 9 – STOCKHOLDERS’ DEFICIT

The Company is authorized to issue two classes of stock designated as common stock and preferred stock. As of March 31, 2015, the Company is authorized to issue 110,000,000 total shares of stock. Of that amount, 100,000,000 shares are common stock, each having a par value of $0.001. The remaining 10,000,000 shares are preferred stock, each having a par value of $0.001, of which 500,000 shares are designated as Series A Preferred Stock, of which 269,608 are issued and outstanding, 500,000 shares are designated as Series B Preferred Stock, of which 131,347 are issued and outstanding, 4,000,000 shares are designated as Series D Preferred Stock, of which 730,357 shares are issued and outstanding, and 2,000,000 are designated as Series E Preferred Stock, of which 416,533 shares are issued and outstanding.

(a) Cumulative Convertible Preferred Stock

A summary of preferred stock outstanding as of March 31, 2015 is as follows (in thousands, except share data):

Description

Series A Preferred, $0.001 par value per share, 500,000 shares designated,

269,608 shares issued and outstanding, liquidation preference of $975

plus cumulative dividends of $460

1,435

Series B Preferred, $0.001 par value per share, 500,000 shares designated,

131,347 shares issued and outstanding, liquidation preference of $380

plus cumulative dividends of $131

511

Series D Preferred, $0.001 par value per share, 4,000,000 shares designated,

730,357 shares issued and outstanding (net of $1,374 in issuance costs),

liquidation preference of $7,303 plus accrued PIK dividends of $216; cumulative

imputed dividends and beneficial conversion feature of $1,621

7,502

Series E Preferred, $0.001 par value per share, 2,000,000 shares designated,

416,533 shares issued and outstanding (net of $875 in issuance costs),

liquidation preference of $4,165 plus acrued PIK dividends of $144; cumulative

imputed dividends of $110

3,401

Total convertible preferred stock

12,849

Series A Preferred Stock and Series B Preferred Stock

The holders of the Series A and Series B Preferred Stock shall be entitled to receive, when, as, and if declared by the Board of Directors, dividends at an annual rate of 8% of the stated value. The stated value of the Series A Preferred is $4.00 per share and the stated value of the Series B Preferred is $3.20 per share. Dividends shall be cumulative and shall accrue on each share of the outstanding preferred stock from the date of its issue.

The holders of the Series A and Series B Preferred Stock have no voting rights except on matters affecting their rights or preferences. Subject to the rights of the Series D Preferred Stock, upon any liquidation, dissolution or winding-up of the Company, the holders of the Series A (subject to the rights of the Series B Preferred) and Series B Preferred Stock shall be entitled to receive an amount equal to the stated value per share of $4.00 and $3.20, respectively, plus any accrued and unpaid dividends before any payments shall be made to the holders of any common stock or hereinafter issued preferred stock. The Series A Preferred Stock has preference over the Series B Preferred Stock in liquidation.

Each share of Series A Preferred Stock is convertible, at the option of the holder, at a conversion price of $4.00 per share. Each share of Series B Preferred Stock is convertible, at the option of the holder, at a conversion price of $3.20 per share.

Series C Preferred Stock

On December 20, 2012, all issued and outstanding shares of Series C Preferred Stock were redeemed using the proceeds generated from the sale of the Series D Preferred Stock.

In connection with the sale of Series E Preferred Stock, on November 12, 2013, the Company filed a Certificate of Elimination of Series C Preferred Stock (the “Series C Certificate of Elimination”), pursuant to which, the 5,000,000 shares of the Company’s preferred stock that had been designated as Series C Preferred Stock were returned to the status of blank check preferred stock.

Series D Preferred Stock

On December 20, 2012, we filed a Certificate of Designation of Series D Preferred Shares (the “Series D Certificate of Designation”) with the Secretary of State of Delaware. Pursuant to the Series D Certificate of Designation, we designated 4,000,000 shares of our preferred stock as Series D Preferred Stock. The Series D Preferred Stock has a Stated Value of $10.00 per share, votes on an as-converted basis with the common stock, and is convertible, at the option of the holder, into such number of shares of our common stock equal to the number of shares of Series D Preferred Stock to be converted, multiplied by the Stated Value, divided by the Conversion Price in effect at the time of the conversion. The initial Conversion Price is $1.00, subject to adjustment in the event of stock splits, stock dividends and similar transactions, and in the event of subsequent equity sales at a lower price per share, subject to certain exceptions. As a result of the private placement closed on August 15, 2013 and August 21, 2013, the Conversion Price of the Series D Preferred Stock was reduced to $0.90. As a result of the private placement closed on November 12, 2013 and November 22, 2013, the Conversion Price of the Series D Preferred Stock was reduced to $0.71. As a result of the reduction in conversion price, the Company recorded a contingent beneficial conversion feature of $1.3 million. The Series D Preferred Stock entitles the holder to cumulative dividends, payable quarterly, at an annual rate of (i) 8% of the Stated Value during the three year period commencing on the date of issue, and (ii) 12% of the Stated Value commencing three years after the date of issue. We may, at our option, pay dividends in PIK Shares, in which event the applicable dividend rate will be 12% and the number of such PIK Shares issuable as a dividend will be equal to the aggregate dividend payable divided by the lesser of (x) the then effective Conversion Price or (y) the average volume weighted average price of the Company’s common stock for the five prior consecutive trading days. In April 2014, the Company issued 26,157 Series D Preferred Stock PIK dividend shares, for previously accrued dividends. The Board of Directors intends to declare a PIK dividend payable in the form of shares of Series D Preferred Stock. The dividends will be payable to holders of record as of March 31, 2015 for accrued dividends for the period of January 1, 2015 to March 31, 2015. As those shares were not issued as of March 31, 2015, they have not been included in the Series D Preferred Stock balance at March 31, 2015. As such, the Company recorded an estimated dividend payable in Current Liabilities in the in the unaudited condensed consolidated balance sheets at March 31, 2015 at an estimated fair value of $216,000.

Upon any liquidation, dissolution or winding-up of our Company, holders of Series D Preferred Stock will be entitled to receive, for each share of Series D Preferred Stock, an amount equal to the Stated Value of $10.00 per share plus any accrued but unpaid dividends thereon before any distribution or payment may be made to the holders of any common stock, Series A Preferred Stock, Series B Preferred Stock, or subsequently issued preferred stock.

In addition, commencing on the trading day on which the closing price of the common stock is greater than $2.00 for thirty consecutive trading days with a minimum average daily trading volume of at least 5,000 shares for such period, and at any time thereafter, the Company may, in its sole discretion, effect the conversion of all of the outstanding shares of Series D Preferred Stock to common stock (subject to the condition that, all of the shares issuable upon such conversion may be re-sold without limitation under an effective registration statement or pursuant to Rule 144 under the Securities Act of 1933, as amended).

Pursuant to the Series D Certificate of Designation, commencing two years from the termination or expiration of the offering of the Series D Preferred Stock (which termination occurred on December 31, 2012), and at any time thereafter, the Company in its sole discretion may redeem all of the outstanding shares of Series D Preferred Stock at a purchase price of $10.00 per share plus any accrued but unpaid dividends.

Series E Preferred Stock

In November 2013, the Company issued 409,000 shares of Series E Preferred for cash consideration totaling $4,090,000. In conjunction with the issuance, the Company incurred issuance costs totaling $875,000, consisting of placement fees of $327,000, legal and other expenses of $270,000, and issued 818,000 warrants to purchase shares of common stock with an exercise price of $0.55 per share to the placement agent with an estimated fair value of $278,000 determined using the Black Scholes option valuation pricing model. The fair value calculation was prepared using the following assumptions: Stock price: $0.47; expected term: 2.5 years; risk free rate of interest of 0.44%; volatility of 143%; and dividend yield of $0.

On November 12, 2013, the Company filed a Certificate of Designation of Series E Preferred Stock (the “Series E Certificate of Designation”) with the Secretary of State of Delaware. Pursuant to the Series E Certificate of Designation, we designated 2,000,000 shares of the Company’s preferred stock as Series E Preferred Stock. The Series E Preferred Stock has a Stated Value of $10.00 per share, does not have voting rights, and is convertible, at the option of the holder, into such number of shares of common stock equal to the number of shares of Series E Preferred Stock to be converted, multiplied by the Stated Value, divided by the Conversion Price in effect at the time of the conversion. The initial Conversion Price is $0.50, subject to adjustment in the event of stock splits, stock dividends and similar transactions, and in the event of subsequent equity sales at a lower price per share, subject to certain exceptions.

The Series E Preferred Stock entitles the holder to cumulative dividends (subject to the prior dividend rights of the Company’s Series D Preferred Stock), payable quarterly, at an annual rate of (i) 10% of the Stated Value during the three year period commencing on the date of issue, and (ii) 14% of the Stated Value commencing three years after the date of issue. We may, at our option (subject to certain conditions), pay dividends in PIK shares, in which event the applicable dividend rate will be 14% and the number of shares issuable as a dividend will be equal to the aggregate dividend payable divided by the lesser of (x) the then effective Conversion Price or (y) the average volume weighted average price of our common stock for the five prior consecutive trading days. In April 2014, the Company issued 7,533 Series E Preferred Stock PIK dividend shares, for previously accrued dividends. The Board of Directors intends to declare a PIK dividend payable in the form of shares of Series E Preferred Stock. The dividends will be payable to holders of record as of March 31, 2015 for accrued dividends for the period of January 1, 2015 to March 31, 2015. As those shares were not issued as of March 31, 2015, they have not been included in the Series E Preferred Stock balance March 31, 2015. As such, the Company recorded an estimated dividend payable in Current Liabilities in the unaudited condensed consolidated balance sheets at March 31, 2015 at an estimated fair value of $144,000.

Upon any liquidation, dissolution or winding-up of our Company, holders of Series E Preferred Stock will be entitled to receive (following payment in full of amounts owed to in respect of the Company’s Series D Preferred Stock), for each share of Series E Preferred Stock, an amount equal to the Stated Value of $10.00 per share plus any accrued but unpaid dividends thereon before any distribution or payment may be made to the holders of any common stock, Series A Preferred Stock, Series B Preferred Stock, or subsequently issued preferred stock.

In addition, commencing on the trading day on which the closing price of the common stock is greater than $1.35 for thirty consecutive trading days with a minimum average daily trading volume of at least 10,000 shares for such period, and at any time thereafter, the Company may, in our sole discretion, effect the conversion of all of the outstanding shares of Series E Preferred Stock to common stock (subject to the condition that, all of the shares issuable upon such conversion may be re-sold without limitation under an effective registration statement or pursuant to Rule 144 under the Securities Act of 1933, as amended).

On November 12, 2013, we filed Amendment No. 2 to our Certificate of Designation of Series A Preferred Stock (the “Series A Amendment”), and Amendment No. 2 to our Certificate of Designation of Series B Preferred Stock (the “Series B Amendment”). Pursuant to the Series A Amendment and the Series B Amendment, the Series A Preferred Stock and the Series B Preferred Stock will be subordinate to the Series E Preferred Stock with respect to any distributions upon any liquidation, dissolution or winding-up of our Company, respectively.

(b) Common Stock

For the three months ended March 31, 2015

There were no common stock issuances for the three months ended March 31, 2015.

For the year ended December 31, 2014

There were no common stock issuances for the year ended December 31, 2014.

For the three months ended March 31, 2015

There were no warrant issuances for the three months ended March 31, 2015.

For the year ended December 31, 2014

There were no warrant issuances for the year ended December 31, 2014.

The following table summarizes information about the Company’s outstanding common stock warrants as of March 31, 2015:

Total

Weighted

Warrants

Total

Average

Date

Strike

Outstanding

Exercise

Issued

Expiration

Price

and Exercisable

Price

Placement Agent Preferred Stock - Class D

12-Dec

17-Dec

1.1

704,200

774,620

Common Stock Investor Warrants *

13-Aug

18-Aug

0.5

1,463,667

731,834

Placement Agent Warrants - Common Stock *

13-Aug

18-Aug

0.5

292,733

146,367

Placement Agent Preferred Stock - Class E

13-Nov

18-Nov

0.55

818,000

449,900

3,278,600

2,102,720

0.64

* warrants classified as liabilities

Esop

Esop	3 Months Ended
Esop	Mar. 31, 2015
Esop [Abstract]
ESOP	NOTE 10 – ESOP



	The Company has an Employee Stock Ownership Plan (the “ESOP”) which covers all non-union employees. The Company’s contribution expense for the three months ended March 31, 2015, was $45,000 representing approximately $38,000 for the ESOP principal payment and $7,000 for the ESOP interest. ESOP shares are allocated to individual employee accounts as the loan obligation of the ESOP to the Company is reduced. These amounts were previously calculated on an annual basis by an outside, independent financial advisor. Compensation costs relating to shares released are based on the fair value of shares at the time they are committed to be released. The unreleased shares are not considered outstanding in the computation of earnings per common share. ESOP compensation expense consisting of both cash contributions and shares committed to be released for the three months ended March 31, 2015 was approximately $17,000. The fair value of the shares was $0.37 per share, based on the average of the daily market closing share price.

Stock_Option_Plan

Stock Option Plan	3 Months Ended
Stock Option Plan	Mar. 31, 2015
Stock Option Plan [Abstract]
STOCK OPTION PLAN	NOTE 11 - STOCK OPTION PLAN



	In December 2010, the Company established the 2010 Stock Option Plan (the “2010 Plan”). The Plan authorizes the issuance of 1,000,000 shares of common stock. Pursuant to the terms of the August 16, 2010 merger agreement, the Company assumed all of Old DecisionPoint’s obligations under their outstanding stock option plans.



	Under the 2010 Plan, common stock incentives may be granted to officers, employees, directors, consultants, and advisors. Incentives under the 2010 Plan may be granted only in the form of non-statutory stock options and all stock options of Old DecisionPoint that were assumed by the Company became non-statutory options on the date of the assumption.



	The 2010 Plan is administered by the Company’s Board of Directors, or a committee appointed by the Board of Directors, which determines recipients and the number of shares subject to the awards, the exercise price and the vesting schedule. The term of stock options granted under the 2010 Plan cannot exceed ten years. Options shall not have an exercise price less than 100% of the fair market value of the Company’s common stock on the grant date, and generally vest over a period of five years. If the individual possesses more than 10% of the combined voting power of all classes of stock of the Company, the exercise price shall not be less than 110% of the fair market of a share of common stock on the date of grant.



	In October 2014, the Company established the 2014 Equity Incentive Plan (the “2014 Plan”). The 2014 Plan authorizes the issuance of 2,500,000 shares of common stock.



	Under the 2014 Plan, common stock incentives may be granted to officers, employees, directors, consultants, and advisors (and prospective directors, officers, managers, employees, consultants and advisors) of the Company and its affiliates can acquire and maintain an equity interest in the Company, or be paid incentive compensation, which may (but need not) be measured by reference to the value of our common stock. The 2014 Plan permits the Company to provide equity-based compensation in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, unrestricted stock and other stock bonus awards and performance compensation awards. For the three months ended March 31, 2015, the Company granted 77,148 stock options under the 2014 Plan.





	The 2014 Plan is administered by the Company’s Board of Directors, or a committee appointed by the Board of Directors, which determines recipients and the number of shares subject to the awards, the exercise price and the vesting schedule. The term of stock options granted under the 2014 Plan cannot exceed ten years. Options shall not have an exercise price less than 100% of the fair market value of the Company’s common stock on the grant date, and generally vest over a period of five years. If the individual possesses more than 10% of the combined voting power of all classes of stock of the Company, the exercise price shall not be less than 110% of the fair market of a share of common stock on the date of grant.



	A summary of the status of the plans as of March 31, 2015, and information with respect to the changes in options outstanding is as follows:



										Weighted -
				Options						Average		Aggregate
				Available			Options			Exercise		Intrinsic
				for Grant			Outstanding			Price		Value

		31-Dec-14			2,114,106			1,385,894		$	0.56	$	-
		Granted			(77,148	)		77,148			0.5		-
		Exercised			-			-			-		-
		Forfeited			-			-			-		-
		31-Mar-15			2,036,958			1,463,042		$	0.56	$	-

		Exercisable options at March 31, 2015						860,980		$	0.7	$	-




	The following table summarizes information about stock options outstanding as of March 31, 2015:



					Options Outstanding								Options Exercisable
								Weighted-							Weighted-
								Average			Weighted-				Average			Weighted-
		Range of						Remaining			Average				Remaining			Average
		Exercise			Number			Contractual			Exercise		Number		Contractual			Exercise
		Prices			Outstanding			Life (Years)			Price		Exercisable		Life (Years)			Price

		$0.31 - $0.53			1,319,889			3.19		$	0.4		728,889		2.14		$	0.47
		$1.33 - $2.03			88,874			1.76			1.9		88,874		1.76		$	1.9
		$2.06 - $4.34			54,279			6.21			2.17		43,217		6.21			2.17

	Total			1,463,042			3.21		$	0.56		860,980		2.3		$	0.7






No awards were exercised during the three months ended March 31, 2015 and 2014, respectively. The total fair value of awards vested for the three months ended March 31, 2015 and 2014 was $17,952 and $1,261, respectively.



Stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as expense over the required service period, which is generally equal to the vesting period. The fair value of options granted to during the three months ended March 31, 2015, was $18,000. The fair value of options granted during the three months ended March 31, 2014, was $39,000. The fair values of options presented was estimated using the Black-Scholes option-pricing model with the following assumptions:





			For the Three Months Ended
			March 31,
			2015	2014

Expected term			1.5 years	1.5 years
Expected volatility			134.24%	152.20%
Dividend yield			0%	0%
Risk-free interest rate			0.41%	0.26%



The Company estimates expected volatility using historical volatility of its common stock over a period equal to the expected life of the options. The expected term of the awards represents the period of time that the awards are expected to be outstanding. Management considered expectations for the future to estimate employee exercise and post-vest termination behavior. The Company does not intend to pay common stock dividends in the foreseeable future, and therefore has assumed a dividend yield of zero. The risk-free interest rate is the yield on zero-coupon U.S. Treasury securities for a period that is commensurate with the expected term of the awards.

Employee stock-based compensation costs for the three months ended March 31, 2015 and 2014, was $33,000 and $10,000, respectively, and is included in selling, general and administrative expense in the accompanying unaudited condensed consolidated statements of operations. As of March 31, 2015, total unrecognized estimated employee compensation cost related to stock options granted prior to that date was $147,000 which is expected to be recognized over a weighted-average vesting period of 2.55 years.

The weighted-average fair value on the grant date of options granted during the three months ended March 31, 2015 and 2014, was $0.23 and $0.34, respectively.

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
Commitments and Contingencies	Mar. 31, 2015
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 12 – COMMITMENTS AND CONTINGENCIES



	Leases - The Company leases its facilities and certain equipment under various operating leases which expire at various dates through fiscal 2020 and require us to pay a portion of the related operating expenses such as maintenance, property taxes, and insurance. There have been no material changes to our lease arrangements during the three months ended March 31, 2015. Please refer to Note 15 to the audited consolidated financial statements for the year ended December 31, 2014, included in the Company’s Annual Report on Form 10-K filed with the SEC on March 18, 2015.

	Rent expense for the three months ended March 31, 2015 and 2014, was $128,000 and $132,000, respectively.

	Apex Obligation - The Company entered into an employment agreement with Donald Dalicandro, the Former Chief Executive Officer of Apex, as a result of the Apex acquisition. The agreement calls for annual bonus upon achieving certain results of operation at Apex for the 12 months ending July 31, 2013, 2014, and 2015. Such bonuses are considered additional contingent purchase consideration as the Company is obligated to pay the bonus regardless of whether or not his employment is retained. The fair value of the bonus was calculated to be approximately CDN$160,000 (US$153,000 at the Apex Closing Date). At March 31, 2015, there is CDN$0 (US$0) recorded in accrued bonus in the consolidated financial statements.



	Contingencies - In addition to the matter discussed below, from time to time the Company is subject to the possibility of involvement in litigation incidental to the conduct of our business. When applicable, we record accruals for contingencies when it is probable that a liability will be incurred and the amount of loss can be reasonably estimated. While the outcome of lawsuits and other proceedings against us cannot be predicted with certainty, in the opinion of management, individually or in the aggregate, no such lawsuits are expected to have a material effect on our financial position or results of operations.

	Wells Notice - On July 2, 2014, the Company received a written “Wells Notice” from the staff of the Securities and Exchange Commission (the “SEC”) indicating that the staff has made a preliminary determination to recommend that the SEC bring an administrative proceeding against the Company. On the same day, Nicholas R. Toms, the Company’s then President and Chief Executive Officer and a then-serving member of the board of directors, also received a Wells Notice. Both Wells Notices relate to allegations that, from late 2009 to early 2011, Mr. Toms was the beneficial owner of shares of common stock of the Company that were held and traded by a Delaware corporation in which Mr. Toms was a 10% owner; that Mr. Toms exercised control over the corporation’s securities account; and that the corporation’s shareholding and trades should have been reflected at the relevant times in public disclosures of Mr. Toms’ other holdings of the Company’s common stock. A Wells Notice is neither a formal allegation of wrongdoing nor a finding that any violations of law have occurred. Rather, it provides the recipient with an opportunity to respond to issues raised by the staff and offer its perspective to the staff prior to any decision to institute proceedings. In response to the Wells Notice, the Company’s Audit Committee conducted an internal review, assisted by new outside legal counsel, and on August 8, 2014, we submitted to the SEC a response to the Wells Notice setting forth why no action should be commenced against us. No proceedings have been commenced against the Company.

	On August 15, 2014, Mr. Toms resigned from his positions as Chief Executive Officer, President and member of the Company’s board of directors. On February 11, 2015, the SEC commenced a formal administrative proceeding against Mr. Toms. On March 26, 2015, the proceeding was stayed pending review by the SEC of Mr. Tom’s signed Offer of Settlement. In regards to the administrative proceeding against Mr. Toms, indemnification agreements are provided to the Company’s Directors and Executive Officers to minimize potential personal liability for actions taken in their capacity as Directors and Officers. The Company has accrued $175,000 as a potential obligation related to the Company’s indemnification of Mr. Toms. As of March 31, 2015, the amount is included as part of Accrued Expenses in the unaudited condensed consolidated balance sheets. As of the date of this filing, no payments have been made under these agreements.

Basis_of_Presentation_Liquidit1

Basis of Presentation, Liquidity and Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2015

Basis of Presentation, Liquidity and Summary of Significant Accounting Policies [Abstract]

Basis of Presentation

Going Concern

Summary of Significant Accounting Policies

Revenue Recognition

Concentration of Risk

Translation of Foreign Currencies

Fair Value Measurement

Level 1 - Quoted prices in active markets for identical assets or liabilities.

Level 3 - Fair value is derived from valuation techniques in which one or more significant inputs are unobservable, including assumptions and judgments made by the Company.

Liabilities Measured and Recorded at Fair Value on a Recurring Basis

The following table summarizes the financial liabilities measured at fair value on a recurring basis as of March 31, 2015 and December 31, 2014 (in thousands):

Significant other

Quoted prices in

Significant other

unobservable

active markets

observable inputs

inputs

Total

Level 1

Level 2

Level 3

Liabilities

Fair value of warrants issued in connection

with share purchase agreement

597

Balance at March 31, 2015

597

Significant other

Quoted prices in

Significant other

unobservable

active markets

observable inputs

inputs

Total

Level 1

Level 2

Level 3

Liabilities

Fair value of warrants issued in connection

with share purchase agreement

519

Balance at December 31, 2014

519

The following table summarizes changes to the fair value of the contingent consideration and derivative warrants, which are Level 3 liabilities (in thousands):

Level 3

Derivative

warrants

Balance at December 31, 2014

519

Adjustments to fair value of warrants (reflected in other income)

Balance at March 31, 2015

597

Assets Measured and Recorded at Fair Value on a Nonrecurring Basis

Income Taxes

Recently Issued Accounting Pronouncements

Basis_of_Presentation_Liquidit2

Basis of Presentation, Liquidity and Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2015
Basis of Presentation, Liquidity and Summary of Significant Accounting Policies [Abstract]
Summary of warrant liability measured at fair value on a recurring basis								Significant other
				Quoted prices in		Significant other		unobservable
				active markets		observable inputs		inputs
		Total		Level 1		Level 2		Level 3

	Liabilities
	Fair value of warrants issued in connection
	with share purchase agreement		597		-		-		597

	Balance at March 31, 2015	$	597	$	-	$	-	$	597



								Significant other
				Quoted prices in		Significant other		unobservable
				active markets		observable inputs		inputs
		Total		Level 1		Level 2		Level 3

	Liabilities
	Fair value of warrants issued in connection
	with share purchase agreement		519		-		-		519

	Balance at December 31, 2014	$	519	$	-	$	-	$	519
Summarizes changes to the fair value of the contingent consideration and derivative warrants		Level 3
		Derivative
		warrants

	Balance at December 31, 2014	$	519
	Adjustments to fair value of warrants (reflected in other income)		78
	Balance at March 31, 2015	$	597

Loss_Per_Common_Share_Tables

Loss Per Common Share (Tables)	3 Months Ended
Loss Per Common Share (Tables)	Mar. 31, 2015
Loss Per Common Share [Abstract]
Schedule of potentially dilutive securities		Three Months Ended March 31,
		2015		2014

	Convertible preferred stock - Series A		270		270
	Convertible preferred stock - Series B		131		131
	Convertible preferred stock - Series D		10,287		9,918
	Convertible preferred stock - Series E		8,331		8,180
	Warrants to purchase common stock		3,279		3,555
	Options to purchase common stock		1,462		592

	Total potentially dilutive securities		23,760		22,646

Warrant_Liability_Tables

Warrant Liability (Tables)	3 Months Ended
Warrant Liability (Tables)	Mar. 31, 2015
Warrant Liability [Abstract]
Schedule of warrant liabilities valued at the closing dates of common stock purchase agreement			Placement Agent Warrants						Investor Warrants
	Warrants		March			December			March			December
	Warrants		31, 2015			31, 2014			31, 2015			31, 2014

	Closing price per share of common stock	$	0.42		$	0.38		$	0.42		$	0.38
	Exercise price per share (range)		0.5			0.5			0.5			0.5
	Expected volatility		147	%		138.3	%		147	%		138.6	%
	Risk-free interest rate		1	%		1.3	%		1	%		1.3	%
	Dividend yield		-			-			-			-
	Remaining expected term of underlying		3.4			3.6			3.4			3.6
	securities (years)		3.4			3.6			3.4			3.6

Goodwill_and_Intangible_Assets1

Goodwill and Intangible Assets (Tables)	3 Months Ended
Goodwill and Intangible Assets (Tables)	Mar. 31, 2015
Goodwill and Intangible Assets [Abstract]
Schedule of transactions effecting goodwill	Balance at December 31, 2014	$	8,202

	Effect of currency translation on Apex		(179	)
	Balance at March 31, 2015	$	8,023
Schedule of intangible assets and accumulated amortization

		31-Mar-15								31-Dec-14
						Accumulated							Accumulated
			Gross			Amortization			Net		Gross		Amortization			Net

	Customer relationships	$	3,033		$	(2,114	)	$	919	$	3,144	$	(2,099	)	$	1,045
	Contractor and resume databases		675			(574	)		101		675		(540	)		135
	Tradename		798			(560	)		238		829		(546	)		283
	Internal use software		2,429			(2,027	)		402		2,607		(2,025	)		582
	Covenant not to compete		102			(102	)		0		103		(103	)		-

		$	7,037		$	(5,377	)	$	1,660	$	7,358	$	(5,313	)	$	2,045

Term_Debt_Tables

Term Debt (Tables)	3 Months Ended
Term Debt (Tables)	Mar. 31, 2015
Term Debt [Abstract]
Schedule of term debt		Balance			Additions		Payments			Amortization of Note Discount		Effect of			Balance
		31-Dec-14										Currency			March 31,
												Translation			2015
	RBC term loan	$	358		$	-	$	(165	)	$	-	$	(28	)	$	165

	BDC term loan		1,462			-		-			-		(118	)		1,344

	SVB term loan		389			-		(83	)		-		-			306

	Note payable seller		200			-		-			-		(16	)		184

	Total note discounts		(16	)		-		-			4		-			(12	)

	Total debt	$	2,393		$	-	$	(279	)	$	4	$	(162	)	$	1,987

	less current portion															(614	)

	Debt, net of current portion														$	1,373

Stockholders_Deficit_Tables

Stockholders' Deficit (Tables)

3 Months Ended

Mar. 31, 2015

Stockholders' Deficit [Abstract]

Schedule of preferred stock outstanding

Description

Series A Preferred, $0.001 par value per share, 500,000 shares designated,

269,608 shares issued and outstanding, liquidation preference of $975

plus cumulative dividends of $460

1,435

Series B Preferred, $0.001 par value per share, 500,000 shares designated,

131,347 shares issued and outstanding, liquidation preference of $380

plus cumulative dividends of $131

511

Series D Preferred, $0.001 par value per share, 4,000,000 shares designated,

730,357 shares issued and outstanding (net of $1,374 in issuance costs),

liquidation preference of $7,303 plus accrued PIK dividends of $216; cumulative

imputed dividends and beneficial conversion feature of $1,621

7,502

Series E Preferred, $0.001 par value per share, 2,000,000 shares designated,

416,533 shares issued and outstanding (net of $875 in issuance costs),

liquidation preference of $4,165 plus acrued PIK dividends of $144; cumulative

imputed dividends of $110

3,401

Total convertible preferred stock

12,849

Schedule of outstanding common stock warrants

Total

Weighted

Warrants

Total

Average

Date

Strike

Outstanding

Exercise

Issued

Expiration

Price

and Exercisable

Price

Placement Agent Preferred Stock - Class D

12-Dec

17-Dec

1.1

704,200

774,620

Common Stock Investor Warrants *

13-Aug

18-Aug

0.5

1,463,667

731,834

Placement Agent Warrants - Common Stock *

13-Aug

18-Aug

0.5

292,733

146,367

Placement Agent Preferred Stock - Class E

13-Nov

18-Nov

0.55

818,000

449,900

3,278,600

2,102,720

0.64

* warrants classified as liabilities

Stock_Option_Plan_Tables

Stock Option Plan (Tables)	3 Months Ended
Stock Option Plan (Tables)	Mar. 31, 2015
Stock Options Plan [Abstract]
Schedule of the summary of the status of the plans and information with respect to the changes in options outstanding									Weighted -
				Options					Average			Aggregate
				Available			Options		Exercise			Intrinsic
				for Grant			Outstanding		Price			Value

		31-Dec-14			2,114,106			1,385,894	$	0.56		$	-
		Granted			(77,148	)		77,148		0.5			-
		Exercised			-			-		-			-
		Forfeited			-			-		-			-
		31-Mar-15			2,036,958			1,463,042	$	0.56		$	-

		Exercisable options at March 31, 2015						860,980	$	0.7		$	-

Schedule of summary of the information about stock options outstanding					Options Outstanding								Options Exercisable
								Weighted-							Weighted-
								Average		Weighted-					Average			Weighted-
		Range of						Remaining		Average					Remaining			Average
		Exercise			Number			Contractual	Exercise		Number			Contractual		Exercise
		Prices			Outstanding			Life (Years)		Price			Exercisable		Life (Years)			Price

		$0.31 - $0.53			1,319,889			3.19	$	0.4			728,889		2.14		$	0.47
		$1.33 - $2.03			88,874			1.76		1.9			88,874		1.76		$	1.9
		$2.06 - $4.34			54,279			6.21		2.17			43,217		6.21			2.17

		Total			1,463,042			3.21	$	0.56			860,980		2.3		$	0.7



Schedule of the summary of fair value using the Black-Scholes option pricing model
			For the Three Months Ended
			March 31,
			2015		2014

	Expected term		1.5 years		1.5 years
	Expected volatility		134.24%		152.20%
	Dividend yield		0%		0%
	Risk-free interest rate		0.41%		0.26%

Basis_of_Presentation_Liquidit3

Basis of Presentation, Liquidity and Summary of Significant Accounting Policies (Details) (Recurring basis [Member], Warrants [Member], USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of warrants issued in connection with share purchase agreement	$597	$519
Ending Balance	597	519
Quoted prices inactive markets (Level 1) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of warrants issued in connection with share purchase agreement
Ending Balance
Significant other observable inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of warrants issued in connection with share purchase agreement
Ending Balance
Significant other unobservable inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of warrants issued in connection with share purchase agreement	597	519
Ending Balance	$597	$519

Basis_of_Presentation_Liquidit4

Basis of Presentation, Liquidity and Summary of Significant Accounting Policies (Details 1) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Fair Value, Liabilities Measured on Recurring Basis [Line Items]
Adjustments to fair value of warrants (reflected in other income)	($78)	$251
Fair Value, Inputs, Level 3 [Member] \| Derivative warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis [Line Items]
Balance at December 31, 2014	519
Adjustments to fair value of warrants (reflected in other income)	78
Balance at March 31, 2015	$597

Basis_of_Presentation_Liquidit5

Basis of Presentation, Liquidity and Summary of Significant Accounting Policies (Detail Textuals)

3 Months Ended

12 Months Ended

3 Months Ended

Mar. 31, 2015

Mar. 31, 2014

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2015

Mar. 31, 2014

Mar. 31, 2015

Mar. 31, 2014

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2015

Mar. 31, 2014

Mar. 31, 2015

Mar. 31, 2014

Mar. 31, 2015

Mar. 31, 2014

USD ($)

CAD

USD ($)

Revenues [Member]

Accounts receivable [Member]

Total purchases [Member]

Accounts Payable [Member]

Customer One [Member]

Customer Two [Member]

Customer One [Member]

Individual Supplier [Member]

Supplier Concentration Risk [Member]

Customer

Subsidiary

Basis of presentation, liquidity and summary of significant accounting policies (Textuals)

Cash, FDIC Insured Amount

$250,000

Number of customers

Total percent of revenues from various customers

10.00%

11.00%

24.00%

25.00%

14.00%

16.00%

24.00%

29.00%

58.00%

60.00%

71.00%

65.00%

Number of vendors

Income tax expense (benefit)

-21,000

22,000

Pre-tax loss

600,000

91,000

Fair value of bonus

153,000

160,000

Fair value of the contingent consideration liability

Fair market value adjustment of warrant liabilities

($78,000)

$251,000

Loss_Per_Common_Share_Details

Loss Per Common Share (Details)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities	23,760	22,646
Convertible Preferred stock [Member] \| Series A [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities	270	270
Convertible Preferred stock [Member] \| Series B [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities	131	131
Convertible Preferred stock [Member] \| Series D [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities	10,287	9,918
Convertible Preferred stock [Member] \| Series E [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities	8,331	8,180
Warrants to purchase common stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities	3,279	3,555
Options to purchase common stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities	1,462	592

Loss_Per_Common_Share_Detail_T

Loss Per Common Share (Detail Textuals) (Employee Stock Ownership Plan [Member])	Mar. 31, 2015	Mar. 31, 2014
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Employee Stock Ownership Plan [Member]
Loss Per Common Share (Textual)
ESOP shares that have not been committed to be released	0.3	0.4

Warrant_Liability_Details

Warrant Liability (Details) (USD $)	3 Months Ended	12 Months Ended
Warrant Liability (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Placement Agent Warrants [Member]
Derivative [Line Items]
Closing price per share of common stock	$0.42	$0.38
Exercise price per share (range)	$0.50	$0.50
Expected volatility	147.00%	138.30%
Risk-free interest rate	1.00%	1.30%
Dividend yield
Remaining expected term of underlying securities (years)	3 years 4 months 24 days	3 years 7 months 6 days
Investor Warrants [Member]
Derivative [Line Items]
Closing price per share of common stock	$0.42	$0.38
Exercise price per share (range)	$0.50	$0.50
Expected volatility	147.00%	138.60%
Risk-free interest rate	1.00%	1.30%
Dividend yield
Remaining expected term of underlying securities (years)	3 years 4 months 24 days	3 years 7 months 6 days

Warrant_Liability_Detail_Textu

Warrant Liability (Detail Textuals) (USD $)	3 Months Ended
Warrant Liability (Detail Textuals) (USD $)	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Warrants Liability (Textual)
Estimated fair value of the outstanding warrant liabilities	$597,000		$519,000
Increase/ Decrease in fair value of warrant liabilities	$78,000	$251,000

Business_Combinations_Detail_T

Business Combinations (Detail Textuals) (Asset purchase agreement [Member], Illume Mobile [Member], USD $)	1 Months Ended
	Jul. 31, 2012
Asset purchase agreement [Member] \| Illume Mobile [Member]
Business Combinations (Textual)
Total purchase consideration	$1,000,000
Purchase consideration, cash paid	250,000
Purchase consideration, value of shares issued	750,000
Purchase consideration, number of shares issued	617,284
Value of shares issued in conjunction with the acquisition	$697,531

Business_Combinations_Detail_T1

Business Combinations (Detail Textuals 1) (Apex [Member])

0 Months Ended

3 Months Ended

12 Months Ended

0 Months Ended

Jun. 04, 2012

Mar. 31, 2015

Mar. 31, 2014

Dec. 31, 2014

Sep. 30, 2013

Jun. 09, 2014

Jun. 04, 2012

Jun. 09, 2014

USD ($)

CAD

USD ($)

CAD

USD ($)

CAD

USD ($)

CAD

Fair Value [Member]

USD ($)

CAD

USD ($)

CAD

Convertible promissory note [Member]

USD ($)

CAD

Business Combinations (Textual)

Amount paid in consideration to Apex

$4,801,000

5,000,000

$84,000

89,000

Percentage of the fair value of the earn-out

22.22%

77.78%

Undiscounted payment in consideration for Apex achieving certain levels of EBITDA

3,360,700

3,500,000

331,000

341,000

Earn out consideration

400,000

1,033,000

1,076,000

Amount payable in form of convertible promissory note

291,000

311,000

Operating Expenses

713,000

735,000

Fair value of bonus to be paid to CEO

153,000

160,000

Fair value of bonus to be paid to CEO, Accrued bonus

Goodwill_and_Intangible_Assets2

Goodwill and Intangible Assets (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015
Goodwill [Roll Forward]
Balance at December 31, 2014	$8,202
Effect of currency translation on Apex	-179
Balance at March 31, 2015	$8,023

Goodwill_and_Intangible_Assets3

Goodwill and Intangible Assets (Details 1) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Gross	$7,037	$7,358
Accumulated Amortization	-5,377	-5,313
Net	1,660	2,045
Customer relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Gross	3,033	3,144
Accumulated Amortization	-2,114	-2,099
Net	919	1,045
Contractor and resume databases [Member]
Finite-Lived Intangible Assets [Line Items]
Gross	675	675
Accumulated Amortization	-574	-540
Net	101	135
Tradename [Member]
Finite-Lived Intangible Assets [Line Items]
Gross	798	829
Accumulated Amortization	-560	-546
Net	238	283
Internal use software [Member]
Finite-Lived Intangible Assets [Line Items]
Gross	2,429	2,607
Accumulated Amortization	-2,027	-2,025
Net	402	582
Covenant not to compete [Member]
Finite-Lived Intangible Assets [Line Items]
Gross	102	103
Accumulated Amortization	-102	-103
Net	$0

Goodwill_and_Intangible_Assets4

Goodwill and Intangible Assets (Detail Textuals) (USD $)	3 Months Ended
Goodwill and Intangible Assets (Detail Textuals) (USD $)	Mar. 31, 2015
Goodwill and Intangible Assets (Textual)
Effect of foreign currency translation on goodwill	($179,000)
Effect of foreign currency translation on intangible assets	($113,000)

Lines_of_Credit_Detail_Textual

Lines of Credit (Detail Textuals) (Line of Credit [Member])	3 Months Ended		0 Months Ended	3 Months Ended			0 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Feb. 27, 2015	Mar. 31, 2015	Mar. 31, 2015	Dec. 31, 2014	Jun. 04, 2012	Mar. 31, 2015	Dec. 31, 2014
	USD ($)	USD ($)	Silicon Valley Bank ("SVB") [Member]	Silicon Valley Bank ("SVB") [Member]	SVB Loan Agreement [Member]	SVB Loan Agreement [Member]	RBC Credit Agreement [Member]	RBC Credit Agreement [Member]	RBC Credit Agreement [Member]
				USD ($)	Silicon Valley Bank ("SVB") [Member]	Silicon Valley Bank ("SVB") [Member]	Royal Bank of Canada [Member]	Royal Bank of Canada [Member]	Royal Bank of Canada [Member]
					USD ($)	USD ($)	CAD	USD ($)	USD ($)
Line of Credit (Textual)
Aggregate amount of credit facility					$10,000,000		200,000
Outstanding balance on the line of credit					3,500,000	5,800,000		0	58,000
Minimum Tangible Net Worth				8,600,000
Percentage of additional capital raises in tangible net worth				50.00%
Line of credit, covenant terms			The Company entered into an agreement to further amend the original SVB Loan Agreement dated December 15, 2006 to extend the maturity date of the revolving credit line provided thereunder to February 28, 2017. The February 27, 2015 amendment provides for interest at prime plus 3.25% in 2015, and provides for further interest rate reductions upon achievement of certain financial thresholds.
Annual Interest Rate					6.50%	6.50%		4.35%	4.35%
Annual interest rate, Additional percentage							1.50%
Availability under the line of credit					700,000
Interest expense for the lines of credit, including amortization of deferred financing costs	$103,000	$97,000

Term_Debt_Details

Term Debt (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Beginning Balance	$2,393
Additions
Payments	-279
Amortization of Note Discount	4
Effect of Currency Translation	-162
Ending Balance	1,987
less current portion	-614
Debt, net of current portion	1,373	1,580
RBC Term Loan [Member]
Debt Instrument [Line Items]
Beginning Balance	358
Additions
Payments	-165
Amortization of Note Discount
Effect of Currency Translation	-28
Ending Balance	165
BDC Term Loan [Member]
Debt Instrument [Line Items]
Beginning Balance	1,462
Additions
Payments
Amortization of Note Discount
Effect of Currency Translation	-118
Ending Balance	1,344
SVB Term Loan [Member]
Debt Instrument [Line Items]
Beginning Balance	389
Additions
Payments	-83
Amortization of Note Discount
Effect of Currency Translation
Ending Balance	306
Note payable seller [Member]
Debt Instrument [Line Items]
Beginning Balance	200
Additions
Payments
Amortization of Note Discount
Effect of Currency Translation	-16
Ending Balance	184
Note Discount [Member]
Debt Instrument [Line Items]
Beginning Balance	-16
Additions
Payments
Amortization of Note Discount	4
Effect of Currency Translation
Ending Balance	($12)

Term_Debt_Detail_Textuals

Term Debt (Detail Textuals)	3 Months Ended			1 Months Ended		0 Months Ended		3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Jul. 31, 2012	Jun. 04, 2012	Jun. 04, 2012	Jun. 04, 2012	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2015	Dec. 31, 2014
	USD ($)	USD ($)	RBC Term Loan [Member]	Apex [Member]	Apex [Member]	Apex [Member]	Apex [Member]	Apex [Member]	Apex [Member]	Other Assets [Member]	Other Assets [Member]
				RBC Term Loan [Member]	RBC Term Loan [Member]	RBC Term Loan [Member]	RBC Term Loan [Member]	RBC Term Loan [Member]	RBC Term Loan [Member]	USD ($)	USD ($)
				Line of Credit [Member]	Line of Credit [Member]	Term Credit Facility [Member]	Term Credit Facility [Member]	Term Credit Facility [Member]	Term Credit Facility [Member]
				CAD	CAD	USD ($)	CAD	USD ($)	USD ($)
Debt Instrument [Line Items]
Unamortized deferred financing costs										$11,000	$19,000
Aggregate amount of credit facility					2,750,000	2,401,000	2,500,000
Term Loan, Interest percentage						4.00%	4.00%	7.00%
Principal and interest payable period								3 years
Fixed principal amount				70,000
Frequency of repayment								Monthly
Financing costs paid	100,000	100,000						120,000
Percentage of Apex's free cash flow for mandatory repayments of term loan								20.00%
Period of payment for mandatory repayments								30 days
Estimated amount of term loan included in current portion of debt	($614,000)								$0
Term loan and financial covenant, Description			On August 16, 2013 the RBC Credit Agreement was amended and certain financial covenants were modified. Pursuant to the amended credit agreement and commencing with the fiscal year ended December 31, 2013, the Company is required to maintain a fixed coverage ratio, calculated on a consolidated basis of not less than 1.15:1 with a step-up to 1.25:1 as of March 31, 2014, tested on a rolling four quarter basis thereafter and a ratio of funded debt to EBITDA, calculated on an annual consolidated basis of not greater than 3.0:1, tested on a rolling four quarter basis thereafter.

Term_Debt_Detail_Textuals_1

Term Debt (Detail Textuals 1)	3 Months Ended				0 Months Ended	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2015	Jun. 04, 2012	Mar. 31, 2015	Mar. 31, 2015	Jun. 04, 2012
	USD ($)	USD ($)	BDC Term Loan [Member]	BDC Term Loan [Member]	Apex [Member]	Apex [Member]	Apex [Member]	Apex [Member]
				Term Credit Facility [Member]	BDC Term Loan [Member]	BDC Term Loan [Member]	BDC Term Loan [Member]	BDC Term Loan [Member]
				USD ($)	Term Credit Facility [Member]	Term Credit Facility [Member]	Term Credit Facility [Member]	Term Credit Facility [Member]
					CAD	USD ($)	CAD	USD ($)
Debt Instrument [Line Items]
Aggregate amount of credit facility					1,700,000			$1,632,000
Interest rate per annum								12.50%
Maturity date					23-Jun-16
Debt instrument interest extention period					1 year
Line of credit facility extension fee percentage					2.00%
Line of credit facility additional periodic interest payment					20,000
Percentage of Apex's free cash flow for mandatory repayments of term loan					50.00%
Maximum annual cash flow sweep					425,000		425,000
Estimated amount of term loan under mandatory repayments	0
Financing costs paid	100,000	100,000				70,000
Terms of loan agreement, description			The terms of the BDC loan agreement also provide for a fee to BDC in the event of the occurrence of any of the following:(a) if 50% or more of any company comprising Apex or the Company (consolidated assets or shares) is sold or merged with an unrelated entity; or(b) if there is a change of control of Apex and/or the Company prior to the Maturity Date or any extended maturity date of the BDC Term Loan,
Deferred finance costs				10,000		35,000
Note discount				$10,000		$35,000
Percentage of value of company and acquiree paid as bonus on fulfillment of terms			2.00%
Term loan and financial covenant, Description			On August 22, 2013, the BDC Term Loan was amended and certain financial covenants were modified. Pursuant to the amended loan agreement, the Company is required to maintain, for the duration of the investment, a term debt to equity ratio not exceeding 1.1:1 (measured annually); and an adjusted current ratio of 0.40:1 (measured annually) and revised yearly 120 days after each year end. The Company was in compliance with all of our BDC financial covenants as of December 31, 2014.

Term_Debt_Detail_Textuals_2

Term Debt (Detail Textuals 2) (Term Credit Facility [Member], Silicon Valley Bank ("SVB") [Member], USD $)	0 Months Ended	1 Months Ended	3 Months Ended		12 Months Ended
	Feb. 27, 2015	Feb. 27, 2013	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Feb. 01, 2011	Dec. 31, 2010
	Feb. 27, 2015	Subsidiary	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Subsidiary	Dec. 31, 2010
Debt Instrument [Line Items]
Outstanding balance on the line of credit			$306,000		$389,000		$3,000,000
Number of equal monthly installments		36				36
Percent of aggregate amount of the term loan equal to final payment			2.00%
Interest rate		7.50%	9.00%
Final payment recorded as discount			60,000
Excess tangible assets net worth			900,000
Gross proceeds from sale of preferred stock
Additional term loan		1,000,000
Interest expense for the lines of credit, including amortization of deferred financing costs			77,000	109,000
Line of credit, covenant terms	On February 27, 2015, the Company further amended the SVB Loan Agreement to extend the maturity date of the revolving credit line provided thereunder to February 28, 2017. The February 27, 2015 amendment provides for interest at prime plus 3.25% in 2015, and provides for further interest rate reductions upon achievement of certain financial thresholds. The February 27, 2015 amendment contains certain financial covenants				The convertible notes accrues interest of 9% per annum for the first year and 11% for year two.
Description of interest rate					Canadian Dollar equivalent of the market price of our common stock on the day prior to the conversion using a fixed rate of US$1.00 =DN$1.04, or the Canadian Dollar equivalent of US$1.00 =DN$1.04.
Maturity date					30-Jun-16
Note payable seller [Member]
Debt Instrument [Line Items]
Outstanding balance on the line of credit				$184,000	$200,000

Stockholders_Deficit_Details

Stockholders' Deficit (Details) (Cumulative Convertible Preferred Stock [Member], USD $)	Mar. 31, 2015
In Thousands, unless otherwise specified	Mar. 31, 2015
Cumulative Convertible Preferred Stock [Line Items]
Total convertible preferred stock	$12,849
Series A Preferred Stock [Member]
Cumulative Convertible Preferred Stock [Line Items]
Total convertible preferred stock	1,435
Series B Preferred Stock [Member]
Cumulative Convertible Preferred Stock [Line Items]
Total convertible preferred stock	511
Series D Preferred Stock [Member]
Cumulative Convertible Preferred Stock [Line Items]
Total convertible preferred stock	7,502
Series E Preferred Stock [Member]
Cumulative Convertible Preferred Stock [Line Items]
Total convertible preferred stock	$3,401

Stockholders_Deficit_Parenthet

Stockholders' Deficit (Parenthetical) - (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Cumulative Convertible Preferred Stock [Line Items]
Par value of preferred stock (in dollars per share)	$0.00	$0.00
Shares designated	10,000,000	10,000,000
Shares issued	1,547,845	1,547,845
Shares outstanding	1,547,845	1,547,845
Cumulative preferred dividends	$2,322	$2,295
Cumulative Convertible Preferred Stock [Member] \| Series A Preferred Stock [Member]
Cumulative Convertible Preferred Stock [Line Items]
Par value of preferred stock (in dollars per share)	$0.00
Shares designated	500,000
Shares issued	269,608
Shares outstanding	269,608
Liquidation preference	975
Cumulative preferred dividends	460
Cumulative Convertible Preferred Stock [Member] \| Series B Preferred Stock [Member]
Cumulative Convertible Preferred Stock [Line Items]
Par value of preferred stock (in dollars per share)	$0.00
Shares designated	500,000
Shares issued	131,347
Shares outstanding	131,347
Liquidation preference	380
Cumulative preferred dividends	131
Cumulative Convertible Preferred Stock [Member] \| Series D Preferred Stock [Member]
Cumulative Convertible Preferred Stock [Line Items]
Par value of preferred stock (in dollars per share)	$0.00
Shares designated	4,000,000
Shares issued	730,357
Shares outstanding	730,357
Liquidation preference	7,303
Cumulative preferred dividends	1,621
Preferred stock, issuance costs	1,374
Accrued PIK dividends	216
Cumulative Convertible Preferred Stock [Member] \| Series E Preferred Stock [Member]
Cumulative Convertible Preferred Stock [Line Items]
Par value of preferred stock (in dollars per share)	$0.00
Shares designated	2,000,000
Shares issued	416,533
Shares outstanding	416,533
Liquidation preference	4,165
Cumulative preferred dividends	110
Preferred stock, issuance costs	875
Accrued PIK dividends	$144

Stockholders_Deficit_Details_1

Stockholders' Deficit (Details 1) (Warrants [Member], USD $)	3 Months Ended
	Mar. 31, 2015
Class of Warrant or Right [Line Items]
Outstanding common stock warrants, total warrants outstanding and exercisable	$3,278,600
Outstanding common stock warrants total exercise price	2,102,720
Outstanding common stock warrants weighted average exercise price	$0.64
Placement Agent Preferred Stock Class D [Member]
Class of Warrant or Right [Line Items]
Outstanding common stock warrants, date issued	2012 December
Outstanding common stock warrants expiration date	2017 December
Outstanding common stock warrants strike price	$1.10
Outstanding common stock warrants, total warrants outstanding and exercisable	704,200
Outstanding common stock warrants total exercise price	774,620
Common Stock Investor Warrants [Member]
Class of Warrant or Right [Line Items]
Outstanding common stock warrants, date issued	2013 August	[1]
Outstanding common stock warrants expiration date	2018 August	[1]
Outstanding common stock warrants strike price	$0.50	[1]
Outstanding common stock warrants, total warrants outstanding and exercisable	1,463,667	[1]
Outstanding common stock warrants total exercise price	731,834	[1]
Placement Agent Warrants - Common Stock [Member]
Class of Warrant or Right [Line Items]
Outstanding common stock warrants, date issued	2013 August	[1]
Outstanding common stock warrants expiration date	2018 August	[1]
Outstanding common stock warrants strike price	$0.50	[1]
Outstanding common stock warrants, total warrants outstanding and exercisable	292,733	[1]
Outstanding common stock warrants total exercise price	146,367	[1]
Placement Agent Preferred Stock - Class E [Member]
Class of Warrant or Right [Line Items]
Outstanding common stock warrants, date issued	2013 November
Outstanding common stock warrants expiration date	2018 November
Outstanding common stock warrants strike price	$0.55
Outstanding common stock warrants, total warrants outstanding and exercisable	818,000
Outstanding common stock warrants total exercise price	$449,900

[1]	warrants classified as liabilities

Stockholders_Deficit_Detail_Te

Stockholders' Deficit (Detail Textuals) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Class of Stock [Line Items]
Total number of authorized shares	110,000,000
Number of common stock, shares authorized	100,000,000	100,000,000
Common stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares issued	1,547,845	1,547,845
Preferred stock, shares outstanding	1,547,845	1,547,845
Preferred Stock [Member] \| Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	500,000
Preferred stock, shares issued	269,608
Preferred stock, shares outstanding	269,608
Preferred Stock [Member] \| Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	500,000
Preferred stock, shares issued	131,347
Preferred stock, shares outstanding	131,347
Preferred Stock [Member] \| Series D Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	4,000,000
Preferred stock, shares issued	730,357
Preferred stock, shares outstanding	730,357
Preferred Stock [Member] \| Series E Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	2,000,000
Preferred stock, shares issued	416,533
Preferred stock, shares outstanding	416,533

Stockholders_Deficit_Detail_Te1

Stockholders' Deficit (Detail Textuals 1) (USD $)	0 Months Ended	1 Months Ended	3 Months Ended	0 Months Ended
Stockholders' Deficit (Detail Textuals 1) (USD $)	Nov. 12, 2013	Nov. 30, 2013	Mar. 31, 2015	Apr. 30, 2014	Dec. 31, 2014
Dividends Payable [Line Items]
Preferred stock, shares authorized			10,000,000		10,000,000
Series C Preferred Stock [Member]
Dividends Payable [Line Items]
Preferred stock, shares authorized	5,000,000
Series E Preferred Stock [Member]
Dividends Payable [Line Items]
Conversion price per share	$0.50
Exercise price of warrants	$0.50
Stock price	$0.47
Expected term	2 years 6 months
Risk-free interest rate	0.44%
Expected volatility	143.00%
Dividend yield	0.00%
Warrants [Member]
Dividends Payable [Line Items]
Number of common stock called for warrants		818,000
Exercise price of warrants		$0.55
Estimated fair value of warrants		$278,000
Stock price		$0.47
Expected term		2 years 6 months
Risk-free interest rate		0.44%
Expected volatility		143.00%
Dividend yield		0.00%
Cumulative Convertible Preferred Stock [Member] \| Series A Preferred Stock [Member]
Dividends Payable [Line Items]
Stated value of the Preferred per share			$4
Dividend Rate			8.00%
Conversion price per share			$4
Preferred stock, shares authorized			500,000
Cumulative Convertible Preferred Stock [Member] \| Series B Preferred Stock [Member]
Dividends Payable [Line Items]
Stated value of the Preferred per share			$3.20
Dividend Rate			8.00%
Conversion price per share			$3.20
Preferred stock, shares authorized			500,000
Cumulative Convertible Preferred Stock [Member] \| Series D Preferred Stock [Member]
Dividends Payable [Line Items]
Stated value of the Preferred per share			$10
Dividend Rate			8.00%
Conversion price per share			$1
Preferred stock, shares authorized			4,000,000
Reduced conversion price per share			$0.90
Preferred stock dividend payment rate			The Series D Preferred Stock entitles the holder to cumulative dividends, payable quarterly, at an annual rate of (i) 8% of the Stated Value during the three year period commencing on the date of issue, and (ii) 12% of the Stated Value commencing three years after the date of issue. We may, at our option, pay dividends in PIK Shares, in which event the applicable dividend rate will be 12% and the number of such PIK Shares issuable as a dividend will be equal to the aggregate dividend payable divided by the lesser of (x) the then effective Conversion Price or (y) the average volume weighted average price of the Company's common stock for the five prior consecutive trading days.
Minimum closing price of common stock			$2
Minimum average daily trading volume			5,000
Redemption purchase price per share			$10
Contingent beneficial conversion feature recorded as conversion price			1,300,000
Dividend payable, Shares				26,157
Dividend payable estimated fair value			216,000
Cumulative Convertible Preferred Stock [Member] \| Series D Preferred Stock [Member] \| Minimum [Member]
Dividends Payable [Line Items]
Reduced conversion price per share			$0.71
Redemption purchase price per share			$10
Cumulative Convertible Preferred Stock [Member] \| Series D Preferred Stock [Member] \| After the date of issue [Member]
Dividends Payable [Line Items]
Dividend Rate			12.00%
Cumulative Convertible Preferred Stock [Member] \| Series E Preferred Stock [Member]
Dividends Payable [Line Items]
Stated value of the Preferred per share			$10
Conversion price per share			$0.50
Preferred stock, shares authorized			2,000,000
Preferred stock dividend payment rate			The Series E Preferred Stock entitles the holder to cumulative dividends (subject to the prior dividend rights of the Company's Series D Preferred Stock), payable quarterly, at an annual rate of (i) 10% of the Stated Value during the three year period commencing on the date of issue, and (ii) 14% of the Stated Value commencing three years after the date of issue. We may, at our option (subject to certain conditions), pay dividends in PIK shares, in which event the applicable dividend rate will be 14% and the number of shares issuable as a dividend will be equal to the aggregate dividend payable divided by the lesser of (x) the then effective Conversion Price or (y) the average volume weighted average price of our common stock for the five prior consecutive trading days.
Liquidation price per share			$10
Minimum closing price of common stock			$1.35
Minimum average daily trading volume			10,000
Dividend payable, Shares			7,533
Dividend payable estimated fair value			144,000
Number of preferred stock issued for cash consideration		409,000
Value of preferred stock issued for cash consideration		4,090,000
Issuance cost		875,000
Placement Fees		327,000
Legal And Other Expenses		$270,000

Esop_Detail_Textuals

Esop (Detail Textuals) (Employee Stock Ownership Plan (the "ESOP") [Member], USD $)	3 Months Ended
	Mar. 31, 2015
Employee Stock Ownership Plan (the "ESOP") [Member]
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]
Contribution expense	$45,000
ESOP principal payment	38,000
ESOP interest expenses	7,000
ESOP compensation expenses	$17,000
Fair value of the shares	$0.37

Stock_Option_Plan_Details

Stock Option Plan (Details) (2010 Stock Option Plan (the "Plan") [Member], USD $)	3 Months Ended
	Mar. 31, 2015
2010 Stock Option Plan (the "Plan") [Member]
Options Available for Grant
Options Available for Grant, December 31, 2014	2,114,106
Options Available for Grant, Granted	-77,148
Options Available for Grant, Exercised
Options Available for Grant, Forfeited
Options Available for Grant, March 31, 2015	2,036,958
Options Outstanding
Options Outstanding, December 31, 2014	1,385,894
Options Outstanding, Granted	77,148
Options Outstanding, Exercised
Options Outstanding, Forfeited
Options Outstanding, March 31, 2015	1,463,042
Exercisable options at March 31, 2015	860,980
Weighted- Average Exercise Price
Weighted - Average Exercise Price, December 31, 2014	$0.56
Weighted - Average Exercise Price, Granted	$0.50
Weighted - Average Exercise Price, Exercised
Weighted - Average Exercise Price, Forfeited
Weighted - Average Exercise Price, March 31, 2015	$0.56
Weighted Average Exercise Price, Exercisable options at March 31, 2015	$0.70
Aggregate Intrinsic Value
Aggregate Intrinsic Value, December 31, 2014
Aggregate Intrinsic Value, Granted
Aggregate Intrinsic Value, Exercised
Aggregate Intrinsic Value, Forfeited
Aggregate Intrinsic Value, March 31, 2015
Aggregate Intrinsic Value, Exercisable options at March 31, 2015

Stock_Option_Plan_Details_1

Stock Option Plan (Details 1) (2010 Stock Option Plan (the "Plan") [Member], USD $)	3 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Options Outstanding	1,463,042	1,385,894
Options Outstanding Weighted Average Remaining Contractual Life (Years)	3 years 2 months 16 days
Options Outstanding Weighted Average Exercise Price	$0.56	$0.56
Number of Options Exercisable	860,980
Options Exercisable Weighted Average Remaining Contractual Life (Years)	2 years 3 months 18 days
Options Exercisable Weighted Average Exercise Price	$0.70
Exercise Price $ 0.31 - $0.53 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Minimum Range of Exercise Prices	$0.31
Maximum Range of Exercise Prices	$0.53
Number of Options Outstanding	532,475
Options Outstanding Weighted Average Remaining Contractual Life (Years)	3 years 2 months 9 days
Options Outstanding Weighted Average Exercise Price	$0.50
Number of Options Exercisable	728,889
Options Exercisable Weighted Average Remaining Contractual Life (Years)	2 years 1 month 21 days
Options Exercisable Weighted Average Exercise Price	$0.50
Exercise Price $ 1.33 - 2.03 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Minimum Range of Exercise Prices	$1.33
Maximum Range of Exercise Prices	$2.03
Number of Options Outstanding	88,874
Options Outstanding Weighted Average Remaining Contractual Life (Years)	1 year 9 months 4 days
Options Outstanding Weighted Average Exercise Price	$1.90
Number of Options Exercisable	88,874
Options Exercisable Weighted Average Remaining Contractual Life (Years)	1 year 9 months 4 days
Options Exercisable Weighted Average Exercise Price	$1.90
Exercise price $ 2.06 - 4.34 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Minimum Range of Exercise Prices	$2.06
Maximum Range of Exercise Prices	$4.34
Number of Options Outstanding	54,279
Options Outstanding Weighted Average Remaining Contractual Life (Years)	6 years 2 months 16 days
Options Outstanding Weighted Average Exercise Price	$2.17
Number of Options Exercisable	43,217
Options Exercisable Weighted Average Remaining Contractual Life (Years)	6 years 2 months 16 days
Options Exercisable Weighted Average Exercise Price	$2.17

Stock_Option_Plan_Details_2

Stock Option Plan (Details 2)	3 Months Ended
Stock Option Plan (Details 2)	Mar. 31, 2015	Mar. 31, 2014
Stock Option Plan [Abstract]
Expected term	1 year 6 months	1 year 6 months
Expected volatility	134.24%	152.20%
Dividend yield	0.00%	0.00%
Risk-free interest rate	0.41%	0.26%

Stock_Option_Plan_Detail_Textu

Stock Option Plan (Detail Textuals) (USD $)	3 Months Ended
Stock Option Plan (Detail Textuals) (USD $)	Mar. 31, 2015	Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term of stock option granted	1 year 6 months	1 year 6 months
Total fair value of stock option awards vested	$17,952	$1,261
Fair value of options granted to employees	18,000	39,000
Employee stock-based compensation cost	33,000	10,000
Unrecognized estimated employee compensation cost	$147,000
Weighted-average vesting period, expected to be recognized	2 years 6 months 18 days
Weighted-average fair value on the grant date of options granted	$0.23	$0.34
2010 Stock Option Plan (the "Plan")
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common stock, shares authorized	1,000,000
Stock option granted	77,148
Term of stock option granted	10 years
Percentage of exercise price to market value of common stock	100.00%
Vested period of stock option	5 years
Percentage of voting power of common stock	10.00%
Maximum percentage of fair market of a share of common stock	110.00%
2014 Stock Option Plan (the "Plan")
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common stock, shares authorized	2,500,000
Stock option granted	77,148
Percentage of exercise price to market value of common stock	100.00%
Vested period of stock option	5 years
Percentage of voting power of common stock	10.00%
Maximum percentage of fair market of a share of common stock	110.00%

Commitments_and_Contingencies_

Commitments and Contingencies (Details Textuals)	3 Months Ended				12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2015	Dec. 31, 2014
	USD ($)	USD ($)	Apex [Member]	Apex [Member]	Apex [Member]
			USD ($)	CAD	USD ($)
Employment Agreement [Line Items]
Rental expense	$128,000	$132,000
Fair value of bonus to be paid to CEO			153,000	160,000
Fair value of bonus to be paid to CEO, Accrued bonus			0	0	0
Acquire business, percentage of owner Mr.Toms	10.00%
Potential obligation related to acquire business of Mr. Toms	$175,000